Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3036782	pf-gluk	mmol/l (mmol/l)	3141	4110	0.17%
3036782	pf-gluk	— (—)	367	393	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other pulmonary diagnosis

672

476

7.14

317.44

1.4

1.2

6.21

6.70

mmol/l

2.56

618

438

Other pleural conditions

775

193

49.34

307.65

1.5

1.2

5.89

7.14

mmol/l

4.34

721

184

All pneumoniae

1246

1740

5.02

307.65

1.3

6.42

6.21

mmol/l

1.16

1142

1620

Heart failure, not strict

1017

1370

5.23

307.65

1.4

1.3

7.10

5.64

mmol/l

31.62

949

1251

Pneumonia, organism unspecified

1178

1643

5.28

307.65

1.4

1.3

6.42

6.21

mmol/l

1.12

1081

1534

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1242

1748

5.08

307.65

1.3

6.42

6.22

mmol/l

1.13

1137

1629

Suppurative and necrotic conditions of lower respiratory tract

334

186

21.32

307.65

1.5

1.4

4.49

6.56

mmol/l

11.80

281

176

All-cause Heart Failure

919

1364

4.99

307.65

1.4

1.3

7.23

5.77

mmol/l

29.07

867

1248

Heart failure,strict

875

1039

6.26

307.65

1.4

1.3

7.23

5.57

mmol/l

34.74

826

954

1149

1429

5.12

307.65

1.4

1.3

6.42

6.20

mmol/l

1.18

1054

1342

Pyothorax

303

148

25.33

307.65

1.5

1.4

4.32

6.45

mmol/l

11.82

250

142

Influenza and pneumonia

1243

1715

4.84

307.65

1.4

1.3

6.41

6.20

mmol/l

1.19

1135

1603

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

577

630

8.05

307.65

1.4

5.71

6.64

mmol/l

7.06

546

575

Lung cancer and mesothelioma

540

198

24.77

307.65

1.4

1.2

5.70

6.94

mmol/l

6.96

515

176

Pneumonias (Asthma/COPD co-morbidities)

1245

1739

5.04

307.65

1.4

1.3

6.42

6.21

mmol/l

1.21

1140

1620

Heart failure, strict

950

1387

5.07

307.65

1.4

1.3

7.23

5.77

mmol/l

30.01

896

1271

Pleural effusion

1375

310

56.40

307.65

1.5

1.2

5.87

7.06

mmol/l

6.95

1297

282

Other diseases of pleura

1842

857

20.75

307.65

1.5

1.2

6.02

6.84

mmol/l

9.84

1726

778

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1149

1429

5.12

307.65

1.4

1.3

6.42

6.20

mmol/l

1.18

1054

1342

Excluding asthma or asthma-COPD overlap

657

476

6.98

305.16

1.4

1.2

6.28

6.70

mmol/l

1.98

607

438

COPD differential diagnosis

653

476

6.94

301.89

1.4

1.2

6.28

6.70

mmol/l

1.95

604

438

ILD differential diagnosis

652

476

6.93

301.06

1.4

1.2

6.28

6.70

mmol/l

1.93

603

438

Other bacterial diseases

1059

2022

3.67

289.44

1.4

1.3

6.55

6.20

mmol/l

2.59

974

1875

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

600

998

5.41

285.63

1.3

6.02

6.67

mmol/l

4.95

559

916

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

462

548

7.34

285.63

1.3

1.4

5.95

6.70

mmol/l

3.95

439

501

Heart failure and antihypertensive medication

443

344

8.77

281.51

1.5

1.3

7.29

5.42

mmol/l

18.71

422

307

Dyspnoea

1015

2190

3.60

278.92

1.4

1.3

6.41

6.26

mmol/l

0.72

956

2007

Asthma, unspecified (mode), excluding more controls

373

315

9.40

275.95

1.4

1.1

6.38

6.50

mmol/l

0.25

340

285

Other medical care

634

1311

4.84

275.76

1.4

1.3

6.07

6.27

mmol/l

0.75

601

1197

COPD (mode)

356

293

9.85

272.29

1.3

1.2

6.34

6.85

mmol/l

1.80

326

260

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

367

429

8.47

269.47

1.3

1.4

5.84

6.70

mmol/l

3.99

346

390

Asthma, excluding more controls

478

337

7.62

245.82

1.3

1.1

6.35

6.41

mmol/l

0.13

434

307

Bacterial infection, other or unspecified

700

1570

4.10

241.76

1.4

1.3

6.37

6.25

mmol/l

0.41

646

1461

Asthma, unspecified (mode)

388

444

7.00

229.46

1.4

1.2

6.41

6.76

mmol/l

1.15

354

406

Malignant neoplasm of respiratory system and intrathoracic organs

481

866

5.33

226.07

1.4

5.61

6.49

mmol/l

6.80

453

796

Renal tubulo-interstitial diseases

919

2163

3.30

221.82

1.4

1.3

6.97

6.04

mmol/l

13.31

858

1991

Asthma (only as main-diagnosis), excluding more controls

407

337

7.25

214.83

1.4

1.1

6.40

6.41

mmol/l

0.02

372

307

Non-ischemic cardiomyopathy

460

729

5.33

209.43

1.5

1.3

6.78

5.72

mmol/l

9.62

438

668

Asthma

497

474

5.67

201.83

1.4

1.2

6.34

6.70

mmol/l

1.53

452

436

Renal failure

650

1614

3.77

199.67

1.4

1.3

7.33

6.08

mmol/l

14.21

603

1485

Later onset COPD, excluding more controls

262

211

9.94

199.30

1.4

1.2

6.26

6.93

mmol/l

2.34

240

185

Abnormalities of breathing

847

1518

3.35

193.13

1.4

1.3

6.26

6.14

mmol/l

0.54

782

1390

Oxycodone

511

1173

4.31

192.12

1.4

1.3

6.00

6.39

mmol/l

2.05

478

1085

Non-small cell lung cancer

367

673

5.71

191.10

1.3

1.4

5.84

6.41

mmol/l

2.59

346

616

Persons encountering health services for specific procedures and health care

979

2054

2.98

188.16

1.4

1.3

6.38

6.20

mmol/l

0.98

913

1876

Bacterial Sepsis

603

1433

3.82

188.08

1.4

1.3

7.01

6.09

mmol/l

9.01

554

1330

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

949

2332

2.95

186.90

1.4

1.3

6.69

6.16

mmol/l

5.24

889

2144

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

185

156

12.81

185.59

1.3

5.74

7.00

mmol/l

2.84

172

143

Diseases of the respiratory system

483

442

5.52

184.90

1.4

1.1

6.28

6.73

mmol/l

1.85

449

411

Bacterial pneumoniae

489

1006

4.38

183.45

1.4

6.55

6.25

mmol/l

0.99

438

937

Abnormal findings on diagnostic imaging of lung

635

1775

3.55

182.68

1.4

1.3

6.07

6.40

mmol/l

1.95

591

1642

Bacterial pneumonia, not elsewhere classified

475

966

4.43

180.77

1.4

1.3

6.55

6.25

mmol/l

1.02

426

900

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

735

2154

3.21

178.53

1.4

1.3

6.14

6.41

mmol/l

1.58

684

1990

Heart failure and bmi 25plus

471

695

4.78

178.52

1.4

1.3

7.16

5.93

mmol/l

13.03

444

622

Implicit Sepsis

771

1902

3.19

177.35

1.4

1.3

7.03

6.09

mmol/l

12.07

713

1755

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

280

425

6.82

176.06

1.3

1.4

5.91

6.82

mmol/l

3.68

260

382

Asthma (mode)

454

476

5.28

174.46

1.4

1.2

6.34

6.70

mmol/l

1.45

417

438

Septicaemia

530

1332

3.90

174.37

1.4

1.3

6.83

6.25

mmol/l

3.22

481

1238

Asthma (only as main-diagnosis)

422

474

5.41

173.83

1.4

1.2

6.40

6.70

mmol/l

1.03

386

436

Explicit Sepsis

539

1402

3.75

167.91

1.4

1.3

6.82

6.08

mmol/l

5.02

490

1296

Other heart diseases, wide

719

1341

3.35

167.24

1.4

1.3

6.69

5.70

mmol/l

13.95

677

1215

Implicit bacterial Sepsis

533

1315

3.79

166.12

1.5

1.3

7.12

6.10

mmol/l

9.60

493

1217

Other heart diseases

389

500

5.19

159.92

1.5

1.2

6.77

5.47

mmol/l

11.93

363

447

Anaemias

206

119

11.66

158.20

1.5

1.2

6.96

5.22

mmol/l

8.09

195

108

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

315

596

5.43

157.69

1.3

1.4

6.03

6.70

mmol/l

3.12

297

543

Valvular heart disease excluding rheumatic fever

485

876

4.11

157.42

1.5

1.3

6.81

5.65

mmol/l

12.70

458

792

Dialysis, with operation codes

247

371

6.94

157.23

1.5

1.3

7.41

5.92

mmol/l

8.16

231

341

Non-rheumatic valve diseases

483

873

4.10

156.38

1.5

1.3

6.82

5.65

mmol/l

12.69

457

790

COPD/asthma related infections

849

1429

3.00

153.61

1.4

1.3

6.37

6.20

mmol/l

0.70

780

1342

COPD/asthma/ILD related infections

849

1429

3.00

153.61

1.4

1.3

6.37

6.20

mmol/l

0.70

780

1342

Other septicaemia

468

1211

3.87

153.03

1.4

1.3

6.89

6.23

mmol/l

3.55

425

1124

Chronic kidney disease

449

1171

3.92

149.14

1.5

1.3

7.46

6.04

mmol/l

12.00

416

1073

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

156

150

11.01

143.03

1.5

1.3

4.86

7.26

mmol/l

9.01

149

136

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

713

1406

3.02

138.63

1.4

1.3

5.89

6.60

mmol/l

7.55

666

1285

Atrial fibrillation and flutter

307

354

5.74

138.51

1.5

1.2

6.60

5.46

mmol/l

7.75

290

312

Malignant neoplasm, wide definition for exclusion

713

1407

3.02

138.48

1.4

1.3

5.89

6.60

mmol/l

7.52

666

1286

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

712

1407

3.02

137.97

1.4

1.3

5.89

6.60

mmol/l

7.65

665

1286

Nephropathy related operations

238

396

6.27

137.18

1.5

1.3

7.45

6.22

mmol/l

4.88

222

365

Malignant neoplasm of bronchus and lung

363

814

4.32

134.21

1.3

1.4

5.91

6.35

mmol/l

1.69

344

747

Atrial fibrillation and flutter with reimbursement

281

298

6.15

133.76

1.4

1.3

6.73

5.50

mmol/l

7.59

265

259

Non-small cell lung cancer, adenocarcinoma, helper endpoint

185

244

8.16

133.38

1.3

1.4

5.74

6.46

mmol/l

1.84

172

229

Non-small cell lung cancer, adenocarcinoma

185

244

8.16

133.38

1.3

1.4

5.74

6.46

mmol/l

1.84

172

229

Acute renal failure

322

717

4.63

133.29

1.5

1.3

7.35

6.02

mmol/l

10.46

302

649

Diseases of arteries, arterioles and capillaries (FINNGEN)

255

292

6.21

127.56

1.4

1.3

6.92

5.50

mmol/l

8.13

236

255

Condition for Implicit Sepsis (Organ dysfunction codes)

742

2016

2.70

125.34

1.4

1.3

7.11

6.03

mmol/l

14.97

684

1864

Pneumothorax

126

110

11.95

122.93

1.5

1.2

5.25

7.37

mmol/l

4.26

115

105

Malignant neoplasm

709

1507

2.81

122.14

1.4

1.3

5.88

6.58

mmol/l

8.03

662

1380

Bacterial pneumonia (organism specified)

516

1525

3.13

119.80

1.4

6.57

6.24

mmol/l

1.29

463

1410

First line medication for Crohn's disease

891

1992

2.46

115.42

1.4

1.3

6.08

6.35

mmol/l

1.83

818

1841

Other diseases of pericardium

108

13.52

112.79

1.6

1.2

6.69

5.99

mmol/l

0.62

Fever of other and unknown origin

515

1605

3.01

112.77

1.4

1.3

6.19

6.22

mmol/l

0.06

475

1479

Early onset COPD, excluding more controls

156

207

7.64

110.34

1.3

1.2

6.52

6.67

mmol/l

0.19

146

186

Cardiomyopathy

216

402

5.50

110.13

1.3

6.68

5.53

mmol/l

4.66

203

363

Malignant neoplasm of mesothelium and soft tissue

134

161

9.01

104.57

1.6

1.4

4.70

6.61

mmol/l

9.99

129

152

Any event in cancer register

685

1557

2.63

104.23

1.4

1.3

5.90

6.51

mmol/l

6.17

636

1426

Cardiac arrhythmias

419

844

3.31

97.85

1.4

1.2

6.55

5.33

mmol/l

17.12

396

764

Oral corticosteroids

852

2312

2.24

93.43

1.4

1.3

6.24

6.30

mmol/l

0.20

781

2140

Any gastric operation

542

945

2.89

93.11

1.4

1.3

6.27

6.23

mmol/l

0.12

505

872

GASTRO-related operations

542

945

2.89

93.11

1.4

1.3

6.27

6.23

mmol/l

0.12

505

872

Non-invasive ventilation

200

382

4.99

90.19

1.4

1.3

6.85

5.30

mmol/l

11.61

180

348

Aplastic and other anaemias

488

1729

2.71

88.66

1.4

6.90

6.23

mmol/l

4.16

456

1590

ILD medications: prednisolone, methylprednisolone, prednisone

849

2189

2.21

87.75

1.4

1.3

6.23

6.26

mmol/l

0.07

780

2026

Continuous positive airway pressure

194

333

5.11

87.08

1.3

7.03

5.23

mmol/l

8.03

174

299

Other disorders of fluid, electrolyte and acid-base balance

340

1014

3.29

87.05

1.3

6.85

6.27

mmol/l

2.71

316

927

Care involving dialysis

137

207

6.88

86.84

1.5

1.3

7.72

6.38

mmol/l

2.99

126

193

Ascites

143

227

6.59

86.58

1.4

6.16

6.29

mmol/l

0.18

132

208

Inflammatory bowel disease treatment related agents

880

2331

2.16

86.42

1.4

1.3

6.21

6.29

mmol/l

0.29

810

2157

Primary_lymphoid and hematopoietic malignant neoplasms

246

620

4.04

86.35

1.4

6.19

6.67

mmol/l

1.70

234

564

Heart failure and coronary heart disease

444

1174

2.88

84.24

1.5

1.4

7.47

6.16

mmol/l

12.71

415

1082

Diseases of arteries, arterioles and capillaries

641

2045

2.36

83.06

1.3

1.4

7.04

6.16

mmol/l

9.57

587

1895

ILD medications

855

2198

2.15

82.32

1.4

1.3

6.28

6.25

mmol/l

0.08

785

2034

Haemorrhage from respiratory passages

345

1034

3.14

81.30

1.3

6.47

6.19

mmol/l

0.98

329

949

Other anaemias

451

1638

2.69

81.15

1.4

6.92

6.23

mmol/l

3.98

422

1507

Metabolic disorders

740

2074

2.23

80.72

1.4

1.3

6.69

6.14

mmol/l

5.10

684

1908

Other and unspecified anaemias

446

1624

2.69

80.32

1.4

6.96

6.22

mmol/l

4.40

417

1493

Cardiomyopathy (excluding other)

154

289

5.45

77.97

1.3

6.81

5.62

mmol/l

3.37

144

256

Cerebrovascular diseases (FINNGEN)

216

364

4.29

74.17

1.4

1.3

6.83

5.49

mmol/l

6.55

202

322

Cardiomyopathies, Primary/intrinsic

147

279

5.39

73.52

1.3

6.92

5.61

mmol/l

3.76

137

247

Covid-19 confirmed case

283

873

3.29

73.44

1.4

6.45

6.28

mmol/l

0.36

273

790

Erysipelas

461

1685

2.52

72.04

1.4

1.3

6.72

6.25

mmol/l

2.39

428

1560

Malaise and fatigue

429

1372

2.63

71.76

1.3

1.4

6.57

6.22

mmol/l

1.44

395

1267

Certain infectious and parasitic diseases

689

1551

2.24

71.33

1.4

1.3

6.37

6.15

mmol/l

1.09

638

1444

Other arrhythmias

405

1146

2.72

71.23

1.4

1.3

6.43

5.73

mmol/l

5.67

382

1035

Asthma-related pneumonia

368

1339

2.78

71.15

1.3

6.44

6.34

mmol/l

0.26

331

1230

Asthma-related pneumonia or sepsis

368

1342

2.78

70.83

1.3

6.44

6.34

mmol/l

0.26

331

1233

Asthma, hospital admissions 3, pneumonia

368

1342

2.78

70.83

1.3

6.44

6.34

mmol/l

0.26

331

1233

Codes for special purposes

364

1330

2.76

69.85

1.4

1.3

6.43

6.23

mmol/l

0.59

349

1210

Provisional assignment of new diseases of uncertain etiology

363

1328

2.76

69.49

1.4

1.3

6.42

6.24

mmol/l

0.54

348

1208

Pulmonary heart disease, diseases of pulmonary circulation

346

1239

2.84

69.22

1.3

1.4

5.93

6.41

mmol/l

2.39

320

1130

COPD

463

1555

2.49

68.55

1.3

1.4

6.37

6.27

mmol/l

0.27

424

1436

Non-allergic asthma (mode), excluding more controls

136

7.27

67.17

1.4

1.2

6.44

6.60

mmol/l

0.20

121

Cardiovascular diseases (excluding rheumatic etc)

315

572

3.20

67.09

1.4

1.2

6.14

5.47

mmol/l

3.83

286

514

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

688

2236

2.10

66.54

1.4

1.3

6.65

6.11

mmol/l

4.80

643

2050

Transplanted organ and tissue status

126

231

5.60

65.57

1.5

1.4

7.29

6.13

mmol/l

2.70

121

210

Benign neoplasm of colon, rectum, anus and anal canal

380

1009

2.71

65.05

1.4

1.3

6.85

6.52

mmol/l

1.01

346

924

Other chronic obstructive pulmonary disease

443

1512

2.47

64.63

1.3

1.4

6.42

6.28

mmol/l

0.45

408

1395

AV-block

178

391

4.20

64.32

1.5

1.3

7.01

5.52

mmol/l

7.28

171

350

Conduction disorders

241

590

3.44

64.07

1.5

1.3

6.87

5.58

mmol/l

8.09

230

536

Hypertensive diseases (excluding secondary)

288

514

3.28

63.84

1.4

1.2

6.72

5.51

mmol/l

7.85

260

461

Pulmonary embolism

310

1099

2.86

63.26

1.4

5.79

6.40

mmol/l

3.12

285

1001

Bleeding

660

2321

2.08

63.15

1.4

1.3

6.63

6.27

mmol/l

2.19

618

2128

Pulmonary heart disease

310

1100

2.86

63.15

1.4

5.79

6.41

mmol/l

3.26

285

1003

General symptoms and signs

761

1878

2.04

62.98

1.3

6.37

6.21

mmol/l

0.71

700

1734

Complications of surgical and medical care, not elsewhere classified

723

2597

2.01

62.60

1.4

1.3

6.51

6.25

mmol/l

1.54

677

2391

DVT of lower extremities and pulmonary embolism

402

1660

2.44

59.77

1.3

1.4

5.89

6.38

mmol/l

2.69

370

1527

Acute tubulo-interstitial nephritis

467

1815

2.30

59.52

1.4

1.3

6.83

6.06

mmol/l

5.96

436

1681

Symptoms and signs involving the circulatory and respiratory systems

642

1520

2.13

59.17

1.3

6.36

6.14

mmol/l

1.09

589

1392

Venous thromboembolism

480

2096

2.24

58.63

1.3

1.4

5.99

6.39

mmol/l

2.19

444

1939

Other chronic obstructive pulmonary disease, including avohilmo

502

1890

2.23

58.61

1.3

1.4

6.38

6.30

mmol/l

0.22

464

1748

Benign neoplasm: Colon

339

977

2.68

57.90

1.4

1.3

6.96

6.55

mmol/l

1.32

305

898

Tramadol

547

1620

2.18

57.45

1.3

6.44

6.34

mmol/l

0.33

505

1500

Valvular operations

146

340

4.37

57.20

1.5

1.3

6.64

5.52

mmol/l

4.13

139

303

Opioids

658

1681

2.07

57.02

1.4

1.3

6.29

mmol/l

0.00

605

1555

Neoplasms

440

967

2.45

56.99

1.4

1.3

6.11

6.34

mmol/l

0.86

407

887

Extracorporeal dialysis

107

193

5.78

56.97

1.5

7.42

6.40

mmol/l

2.24

181

Any reimbursement code in KELA

272

419

3.27

56.97

1.4

1.2

6.44

5.41

mmol/l

6.31

250

385

COPD, hospital admissions

448

1660

2.31

56.90

1.3

1.4

6.42

6.33

mmol/l

0.25

414

1531

Viral pneumonia

125

260

4.90

56.32

1.5

1.4

6.94

6.27

mmol/l

1.40

120

245

L04AD Calcineurin inhibitors

120

242

5.07

56.14

1.5

1.4

7.10

6.15

mmol/l

1.81

115

220

Peripheral artery disease

448

1582

2.31

56.05

1.4

7.46

6.18

mmol/l

12.14

408

1467

COPD, early/later onset

449

1676

2.29

55.70

1.3

1.4

6.40

6.32

mmol/l

0.22

414

1545

Implicit viral Sepsis

194

565

3.49

55.40

1.4

1.3

7.37

6.09

mmol/l

5.66

183

517

Viral Sepsis

194

565

3.49

55.39

1.4

1.3

7.37

6.09

mmol/l

5.66

183

517

Hypertensive heart and/or renal disease

265

696

2.99

55.17

1.4

1.3

7.20

5.62

mmol/l

11.59

246

650

Glomerular diseases

203

615

3.36

54.55

1.4

7.84

6.25

mmol/l

6.74

189

570

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

135

300

4.48

54.54

1.3

5.59

6.90

mmol/l

6.02

129

273

Parasetamol

537

1248

2.21

54.45

1.4

1.3

6.27

6.17

mmol/l

0.28

500

1154

Hypertension, essential

505

1297

2.23

54.37

1.4

1.3

6.80

5.65

mmol/l

10.73

463

1195

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

244

485

3.21

54.11

1.3

1.2

6.08

5.53

mmol/l

2.11

228

437

COPD, hospital admission 2, with asthma infections

350

1204

2.52

53.56

1.3

1.4

6.60

6.35

mmol/l

0.80

320

1104

Presence of cardiac and vascular implants and grafts

450

1518

2.27

53.52

1.4

7.07

6.17

mmol/l

7.41

429

1392

Iron deficiency anaemia

364

1501

2.43

53.47

1.4

1.3

6.79

6.29

mmol/l

2.42

337

1376

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

144

350

4.19

53.38

1.4

6.21

6.75

mmol/l

1.33

132

316

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

134

309

4.42

53.23

1.4

6.21

6.70

mmol/l

1.06

127

278

Paroxysmal tachycardia

147

299

4.19

52.25

1.4

1.2

6.77

5.51

mmol/l

4.76

137

263

All influenza

189

565

3.38

51.70

1.4

1.3

6.86

6.18

mmol/l

2.19

172

529

Type 2 diabetes, wide definition

607

1983

2.01

51.52

1.4

1.3

8.05

5.58

mmol/l

50.60

564

1828

Atherosclerosis, excluding cerebral and coronary sclerosis

424

1511

2.27

51.07

1.3

1.4

7.37

6.17

mmol/l

10.68

386

1402

ILD, hospital admission 2, with pulmonary infections

116

247

4.81

50.98

1.5

1.3

6.65

6.20

mmol/l

0.67

105

230

Pacemaker

355

1452

2.41

50.95

1.4

7.00

6.26

mmol/l

5.27

341

1330

COPD, hospital admissions 3, with asthma pneumonia sepsis

315

1053

2.58

50.89

1.3

1.4

6.59

6.33

mmol/l

0.74

286

970

ILD, hospital admissions 3, with pneumonia sepsis

108

218

5.10

50.61

1.5

1.4

6.61

6.22

mmol/l

0.51

206

Hypo-osmolality and hyponatraemia

180

531

3.44

50.18

1.4

1.3

6.77

6.30

mmol/l

1.20

167

485

Asthma, hospital admission 2, infections

435

1972

2.19

50.18

1.3

6.41

6.27

mmol/l

0.46

392

1823

Asthma-related infections

435

1972

2.19

50.18

1.3

6.41

6.27

mmol/l

0.46

392

1823

Chronic lower respiratory diseases

807

2394

1.83

50.11

1.4

1.3

6.36

6.25

mmol/l

0.43

739

2214

Other CVD (FINNGEN)

105

153

5.49

49.39

1.5

1.2

6.52

5.31

mmol/l

2.85

140

Primary_lymphoid and hematopoietic malignant neoplasms

246

882

2.83

49.35

1.4

6.19

6.36

mmol/l

0.42

234

798

ILD medications: immunosuppressive drugs

405

1750

2.23

49.14

1.4

1.3

6.38

6.27

mmol/l

0.27

375

1618

Non-allergic asthma (mode)

190

5.20

48.16

1.4

1.3

6.44

6.76

mmol/l

0.51

171

COPD related to multimorbidity

392

1477

2.26

47.39

1.4

6.56

6.34

mmol/l

0.69

361

1361

Glomerular disorders in diseases classified elsewhere

148

401

3.78

47.34

1.4

8.57

6.29

mmol/l

8.43

136

373

Polyarthropathies

538

1778

2.03

47.34

1.4

1.3

6.24

6.35

mmol/l

0.35

498

1639

Infections, IBD-co-morbidities

165

328

3.71

47.29

1.5

1.3

6.79

5.39

mmol/l

5.24

150

301

Nutritional anaemias

405

1810

2.20

47.12

1.4

6.81

6.26

mmol/l

3.35

375

1669

Disorders of lipoprotein metabolism and other lipidaemias

601

1945

1.95

46.98

1.4

1.3

6.82

6.16

mmol/l

5.65

551

1787

Cardiovascular diseases

265

505

2.87

46.67

1.4

1.2

6.21

5.45

mmol/l

3.97

241

453

Undetermined asthma, excluding more controls

7.75

45.38

1.4

1.1

5.99

6.59

mmol/l

0.92

Hypertensive diseases

485

1313

2.10

45.01

1.4

1.3

6.75

5.65

mmol/l

9.75

442

1210

Complications of procedures, not elsewhere classified

559

2521

1.93

44.85

1.4

1.3

6.42

6.28

mmol/l

0.58

519

2321

Pain in throat and chest

501

1497

2.05

44.81

1.3

6.34

6.15

mmol/l

0.75

456

1372

Hypertension

484

1313

2.10

44.66

1.4

1.3

6.75

5.65

mmol/l

9.87

441

1210

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

309

990

2.45

44.47

1.3

6.36

6.64

mmol/l

0.86

290

907

Pleural plaque

103

223

4.72

44.38

1.3

1.2

5.97

7.07

mmol/l

2.67

207

Other and unspecified iron deficiency

275

1100

2.53

44.27

1.4

6.87

6.30

mmol/l

2.33

254

1005

Diabetic nephropathy, excluding more controls

162

408

3.38

41.93

1.3

9.64

7.00

mmol/l

11.07

147

376

Insulin medication

457

1948

2.02

41.87

1.4

1.3

9.32

5.57

mmol/l

55.38

422

1797

Codeine

578

1666

1.91

41.42

1.3

6.40

6.30

mmol/l

0.34

534

1541

Hard cardiovascular diseases

562

1920

1.89

40.12

1.4

7.10

6.03

mmol/l

11.24

521

1769

Complications of medical and surgical care

511

2575

1.90

39.71

1.4

1.3

6.57

6.30

mmol/l

1.24

477

2378

Coronary atherosclerosis

519

1744

1.93

39.57

1.4

1.3

7.07

6.08

mmol/l

10.81

480

1607

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

136

273

3.73

39.36

1.5

1.3

6.64

5.43

mmol/l

3.69

123

250

Secondary hypertension

109

6.19

38.95

1.4

1.2

6.88

5.54

mmol/l

2.54

103

Hypertensive Heart Disease

219

669

2.71

38.87

1.3

7.18

5.63

mmol/l

9.13

202

627

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

325

988

2.27

38.34

1.3

6.26

6.69

mmol/l

1.71

302

905

In situ neoplasms

220

805

2.63

38.27

1.3

6.63

6.67

mmol/l

0.06

213

731

Dentinal caries

194

704

2.77

37.69

1.5

1.4

6.52

6.32

mmol/l

0.37

180

651

Other diseases of the respiratory system

216

834

2.63

37.66

1.4

6.71

6.38

mmol/l

0.82

200

762

Other respiratory disorders and diseases

216

834

2.63

37.66

1.4

6.71

6.38

mmol/l

0.82

200

762

Calcific aortic valvular stenosis, operated

305

1345

2.25

37.56

1.4

6.94

6.31

mmol/l

3.43

289

1230

Calcific aortic valvular stenosis

305

1345

2.25

37.56

1.4

6.94

6.31

mmol/l

3.43

289

1230

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

345

1082

2.19

37.39

1.3

6.33

6.67

mmol/l

1.14

319

986

Operations 2 for CAVS

304

1344

2.24

37.21

1.4

6.94

6.31

mmol/l

3.45

289

1229

Calcific aortic valvular stenosis, diagnosis (helper)

304

1344

2.24

37.21

1.4

6.94

6.31

mmol/l

3.45

289

1229

Calcific aortic valvular stenosis, including rheumatic fever

304

1348

2.23

36.86

1.4

6.94

6.30

mmol/l

3.49

289

1233

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

209

496

2.77

36.66

1.3

1.2

6.33

6.87

mmol/l

1.98

197

452

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

209

496

2.77

36.66

1.3

1.2

6.33

6.87

mmol/l

1.98

197

452

Gout

286

1150

2.30

36.56

1.4

1.3

6.37

6.38

mmol/l

0.03

272

1052

Explicit bacterial Sepsis

112

300

3.80

36.46

1.3

6.54

6.29

mmol/l

0.37

101

277

Hyperkalaemia

166

4.97

36.46

1.3

7.54

6.37

mmol/l

2.01

154

Autoimmune diseases excluding thyroid diseases, strict definition

672

2153

1.75

36.19

1.4

1.3

6.70

6.10

mmol/l

4.51

621

1978

Autoimmune diseases excluding thyroid diseases

690

2219

1.73

36.15

1.4

1.3

6.71

6.12

mmol/l

4.66

639

2039

Non-follicular lymphoma, hilmo, excluding all cancers

215

4.36

36.08

1.5

1.3

6.09

6.91

mmol/l

1.66

196

Cardiomyopathy, other and unspecified

167

4.89

36.06

1.4

1.3

6.76

5.79

mmol/l

1.27

151

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

313

973

2.24

35.63

1.3

6.10

6.69

mmol/l

2.99

289

891

Unspecified kidney failure

121

348

3.56

35.54

1.3

1.4

7.05

6.11

mmol/l

1.87

111

318

Dental caries

206

792

2.60

35.36

1.5

1.4

6.51

6.38

mmol/l

0.23

191

732

Pure hypercholesterolaemia

511

1855

1.86

35.13

1.4

1.3

6.83

6.19

mmol/l

4.44

477

1701

Ulcer of lower limb, not elsewhere classified

157

533

3.00

35.06

1.5

1.4

7.66

6.36

mmol/l

4.24

142

493

Cardiodefibrillation

335

1614

2.10

34.78

1.5

1.4

6.45

6.30

mmol/l

0.49

314

1490

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

313

981

2.21

34.71

1.3

6.10

6.70

mmol/l

3.06

288

898

STROKE

374

1269

2.06

34.68

1.4

1.3

7.04

5.66

mmol/l

11.63

347

1168

Other acute lower respiratory infections

382

1846

1.99

34.29

1.3

6.38

6.31

mmol/l

0.18

358

1686

Gout, FINNGEN

286

1319

2.20

33.46

1.4

6.37

6.34

mmol/l

0.06

272

1205

Other disorders of skin and subcutaneous tissue

477

2396

1.83

33.40

1.4

1.3

6.94

6.28

mmol/l

4.07

435

2228

Care involving use of rehabilitation procedures

381

1850

1.97

33.19

1.3

6.58

6.28

mmol/l

1.13

347

1687

L04AA Selective immunosuppressants

161

574

2.84

32.78

1.5

1.4

6.76

6.29

mmol/l

0.95

153

530

Insulin, combination of fast acting with intermediate-acting or long-acting

458

2305

1.84

32.58

1.4

1.3

9.32

5.85

mmol/l

49.00

422

2122

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

608

2159

1.73

32.25

1.4

1.3

8.12

5.53

mmol/l

53.44

565

1994

Diabetes, varying definitions

627

2197

1.71

32.10

1.4

1.3

7.78

5.53

mmol/l

43.76

577

2028

Ischemic heart diseases

534

1879

1.79

32.09

1.4

1.3

6.96

6.04

mmol/l

10.48

489

1730

Diabetes mellitus

627

2197

1.71

31.95

1.4

1.3

7.78

5.53

mmol/l

43.95

577

2028

Insulin, fast-acting

269

1232

2.20

31.87

1.4

1.3

9.82

5.79

mmol/l

42.41

246

1122

Hypothyroidism (congenital or acquired)

130

4.35

31.83

1.5

1.2

5.93

5.22

mmol/l

2.39

119

Later onset COPD

297

1095

2.16

31.75

1.4

6.38

6.34

mmol/l

0.07

272

1013

Major coronary heart disease event

530

1998

1.78

31.72

1.4

7.10

6.16

mmol/l

9.10

490

1843

Benign neoplasms

375

1054

2.02

31.71

1.4

1.3

6.41

6.39

mmol/l

0.03

342

970

Undetermined asthma

119

5.34

31.71

1.4

1.2

5.99

6.71

mmol/l

1.39

108

Insulin, intermediate and long-acting

409

2139

1.89

31.70

1.4

1.3

9.55

5.85

mmol/l

48.31

377

1972

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

196

4.27

31.30

1.3

6.65

7.02

mmol/l

0.44

179

Streptococcal septicaemia

258

3.80

31.22

1.3

6.50

6.48

mmol/l

0.02

239

Myocardial infarction

403

1524

1.91

30.67

1.4

7.05

6.06

mmol/l

7.56

369

1400

Ischaemic heart disease, wide definition

524

1863

1.77

30.39

1.4

1.3

7.02

6.04

mmol/l

11.10

479

1717

Major coronary heart disease event excluding revascularizations

499

1942

1.79

30.35

1.4

7.18

6.16

mmol/l

8.97

457

1793

Diabetes, insulin treatment (Kela reimbursement)

645

2374

1.67

30.24

1.4

1.3

8.13

5.60

mmol/l

54.00

601

2191

Chronic periapical parodontitis

172

669

2.60

29.61

1.5

1.4

6.42

6.37

mmol/l

0.08

160

620

Diseases of oesophagus, stomach and duodenum

670

2492

1.64

29.35

1.4

1.3

6.32

6.30

mmol/l

0.07

617

2310

Hernia of abdominal wall, postoperative

117

371

3.18

29.32

1.3

6.26

6.18

mmol/l

0.11

110

340

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

195

370

2.65

29.29

1.4

1.2

6.47

6.24

mmol/l

0.45

179

336

Depression medications

109

142

3.88

29.19

1.4

1.2

5.81

5.15

mmol/l

1.44

131

Amputation

119

386

3.15

28.86

1.5

1.3

7.91

6.39

mmol/l

4.34

108

359

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

145

526

2.80

28.75

1.5

1.4

6.80

6.32

mmol/l

0.99

138

485

Type 2 diabetes

608

2165

1.67

28.72

1.4

1.3

7.79

5.53

mmol/l

43.29

562

1999

Hypothyroidism, levothyroxine purchases

130

4.13

28.49

1.4

1.2

5.93

5.22

mmol/l

2.42

119

Hypothyroidism and >3 levothyroxin purchases

130

4.13

28.49

1.4

1.2

5.93

5.22

mmol/l

2.42

119

Abnormal findings on examination of blood, without diagnosis

371

1856

1.88

28.42

1.4

6.53

6.28

mmol/l

0.79

339

1712

Endocrine, nutritional and metabolic diseases

454

1264

1.83

28.29

1.4

1.3

6.75

5.43

mmol/l

13.78

423

1161

Insulin, fast-acting or short human

271

1307

2.09

28.18

1.4

1.3

9.78

6.01

mmol/l

38.20

248

1195

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

408

2258

1.81

27.86

1.4

1.3

6.56

6.31

mmol/l

0.92

380

2086

Gout, idiopatic and unspecified

233

1068

2.21

27.81

1.5

1.4

6.39

6.32

mmol/l

0.17

221

970

Antihypertensive medication - note that there are other indications

252

614

2.25

27.79

1.4

1.2

6.38

5.33

mmol/l

6.72

227

558

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

147

433

2.77

27.57

1.3

1.2

6.40

6.88

mmol/l

1.35

136

393

Other respiratory diseases principally affecting the interstitium

178

730

2.47

27.53

1.4

6.66

6.36

mmol/l

0.58

163

671

Hyperlipidaemia, other/unspecified

302

1444

2.00

27.46

1.4

1.3

6.96

6.18

mmol/l

4.13

283

1326

Diabetic nephropathy

164

641

2.57

27.30

1.3

1.4

9.67

7.41

mmol/l

8.92

149

596

Invasive ventilation

231

3.76

27.28

1.3

1.4

6.90

6.46

mmol/l

0.54

216

Diseases of liver

244

1147

2.15

27.23

1.5

1.3

6.80

6.32

mmol/l

1.68

226

1049

Asthma (diagnoses ohter than nonallergic)

533

2729

1.68

27.19

1.4

1.3

6.36

6.29

mmol/l

0.23

489

2527

Peripheral arterial reconstruction

185

780

2.41

26.96

1.4

7.83

6.38

mmol/l

6.55

166

712

Type 1 diabetes

172

702

2.47

26.67

1.3

9.93

5.47

mmol/l

28.40

157

637

695

2307

1.60

26.61

1.3

6.39

6.25

mmol/l

0.54

648

2142

Iron deficiency anaemia secondary to blood loss (chronic)

142

532

2.70

26.45

1.4

6.48

6.34

mmol/l

0.23

131

495

Bronchitis

653

2689

1.60

26.31

1.3

6.32

6.28

mmol/l

0.13

613

2478

Disorders of lens

468

1697

1.75

26.21

1.4

1.3

7.03

6.13

mmol/l

7.40

435

1555

Oedema, not elsewhere classified

214

972

2.21

25.69

1.4

6.58

6.27

mmol/l

0.71

201

890

Cirrhosis of liver, NAS

165

4.25

25.62

1.7

1.4

7.07

6.51

mmol/l

0.88

155

Fall on same level

680

2406

1.58

25.58

1.3

6.42

6.22

mmol/l

0.97

631

2215

malignant neoplasm of female genital organs

109

361

3.06

25.49

1.2

1.3

5.42

6.75

mmol/l

5.48

103

334

Myocardial infarction, strict

368

1465

1.85

25.35

1.3

1.4

7.00

6.06

mmol/l

6.49

333

1346

COPD, hospital admissions 1, only main diagnosis

307

1359

1.94

25.32

1.3

1.4

6.47

6.33

mmol/l

0.33

285

1249

Chronic periodontitis

137

517

2.69

25.20

1.5

1.4

6.54

6.28

mmol/l

0.40

127

486

Gout, strict definition

179

767

2.37

25.19

1.5

1.4

6.56

6.37

mmol/l

0.50

168

694

Diabetes medication

612

2320

1.61

25.01

1.4

1.3

7.96

5.58

mmol/l

46.81

562

2145

Other diseases of blood and blood-forming organs, wide

170

715

2.40

24.86

1.4

6.07

6.38

mmol/l

0.77

159

657

Diseases of pulp and periapical tissues

239

1156

2.08

24.78

1.4

1.3

6.49

6.34

mmol/l

0.34

222

1065

Glucagon-like peptide-1 (GLP-1) analogues

407

1909

1.77

24.78

1.4

1.3

8.24

5.79

mmol/l

28.75

375

1760

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

317

3.17

24.56

1.4

6.24

6.75

mmol/l

0.70

285

Cerebrovascular diseases

520

2265

1.65

24.39

1.4

7.00

6.23

mmol/l

5.86

489

2078

Need for other prophylactic measures

146

4.35

24.24

1.5

1.4

6.18

6.46

mmol/l

0.30

136

Peripheral artery operations in Hilmo

135

516

2.66

24.23

1.5

1.4

7.95

6.25

mmol/l

5.57

122

474

Persons with potential health hazards related to communicable diseases

181

786

2.30

24.01

1.3

6.22

6.08

mmol/l

0.30

164

727

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

262

3.37

23.88

1.4

1.3

6.22

6.79

mmol/l

0.72

235

Amputation of toe

273

3.34

23.83

1.4

8.12

6.35

mmol/l

3.89

259

Other interstitial pulmonary diseases

150

609

2.50

23.81

1.5

1.4

6.62

6.44

mmol/l

0.26

136

561

Acute bronchitis

287

1473

1.92

23.67

1.3

1.4

6.44

6.34

mmol/l

0.23

273

1343

ILD, hospital admissions

148

601

2.50

23.49

1.5

1.4

6.59

6.41

mmol/l

0.25

134

554

Interstitial lung disease endpoints

150

613

2.48

23.49

1.5

1.4

6.62

6.41

mmol/l

0.30

136

565

Interstitial lung disease

150

613

2.48

23.49

1.5

1.4

6.62

6.41

mmol/l

0.30

136

565

Coronary revascularization (ANGIO or CABG)

363

1415

1.80

23.00

1.4

7.09

6.05

mmol/l

7.57

333

1300

Disorders of gallbladder, biliary tract and pancreas

619

2559

1.56

22.80

1.3

6.68

6.22

mmol/l

3.14

581

2359

Intestinal infectious diseases

551

2709

1.59

22.44

1.4

1.3

6.49

6.23

mmol/l

1.26

503

2505

Type 1 diabetes, wide definition, subgroup 1

132

518

2.57

22.36

1.4

1.3

10.57

5.42

mmol/l

30.67

118

475

388

2076

1.72

22.31

1.3

6.23

6.26

mmol/l

0.05

354

1914

Enterocolitis due to Clostridium difficile

107

379

2.87

22.30

1.5

1.3

6.79

6.60

mmol/l

0.22

354

Diseases of the digestive system

330

1840

1.80

22.26

1.4

1.3

6.56

6.29

mmol/l

0.89

311

1696

Alcohol use disorder, Swedish definition

374

2008

1.74

22.14

1.3

6.25

6.26

mmol/l

0.01

341

1848

Secondary uncertain malignant neoplasm

123

473

2.64

21.89

1.5

1.4

6.32

6.43

mmol/l

0.18

118

441

Senile cataract

438

1614

1.69

21.85

1.4

1.3

6.89

6.13

mmol/l

5.42

407

1481

Codeine or tramadol medication

690

2521

1.52

21.76

1.3

6.41

6.24

mmol/l

0.80

639

2330

COPD-related respiratory insufficiency

123

476

2.63

21.64

1.3

1.4

6.99

6.48

mmol/l

0.89

113

439

Coronary artery bypass grafting

258

1011

1.96

21.54

1.4

7.08

6.06

mmol/l

5.08

242

928

ILD, hospital admissions 1, main diag only

134

545

2.50

21.26

1.4

6.60

6.42

mmol/l

0.24

120

508

Other bacterial intestinal infections

142

593

2.42

21.19

1.5

1.4

6.84

6.35

mmol/l

1.04

128

543

Benign neoplasm: Colon, unspecified

148

628

2.36

21.02

1.4

6.76

6.62

mmol/l

0.24

128

577

Disorders of choroid and retina

529

2445

1.58

20.96

1.4

1.3

7.21

6.20

mmol/l

9.46

495

2252

Disorders resulting from impaired renal tubular function

108

4.68

20.92

1.6

1.4

7.34

6.53

mmol/l

0.79

101

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

367

2152

1.71

20.91

1.3

6.65

6.30

mmol/l

1.42

341

1989

Persons encountering health services in other circumstances, wide

725

2525

1.49

20.80

1.4

1.3

6.46

6.23

mmol/l

1.19

672

2333

Emergency coronary revascularization (for ACS)

438

1915

1.65

20.64

1.4

7.05

6.22

mmol/l

5.96

406

1761

Gout, unspecified

186

881

2.14

20.60

1.5

1.4

6.51

6.35

mmol/l

0.40

176

800

Type 1 diabetes, wide definition

140

588

2.40

20.54

1.4

1.3

10.36

5.49

mmol/l

29.99

126

536

Asthma/COPD (KELA code 203)

532

2391

1.57

20.51

1.4

1.3

6.46

6.25

mmol/l

0.91

494

2211

Pain in limb

473

2124

1.62

20.51

1.3

6.59

6.25

mmol/l

1.60

442

1959

392

2119

1.66

19.77

1.3

6.23

6.25

mmol/l

0.05

358

1954

Type 2 diabetes, definitions combined

553

2127

1.56

19.75

1.3

7.50

5.54

mmol/l

32.74

513

1963

Diarrhoea and gastroenteritis of presumed infectious origin

399

2201

1.65

19.68

1.3

6.41

6.21

mmol/l

0.73

368

2030

Other CVD

169

786

2.17

19.61

1.4

6.60

6.40

mmol/l

0.36

160

715

Type 2 diabetes, strict (exclude DM1)

555

2144

1.55

19.49

1.3

7.51

5.55

mmol/l

33.05

515

1976

Abnormalities of heart beat

193

937

2.05

19.42

1.4

1.3

6.59

6.16

mmol/l

1.70

178

859

Benign neoplasm of colon, rectum, anus and anal canal

422

2356

1.62

19.36

1.4

1.3

6.84

6.29

mmol/l

2.90

386

2183

GI-bleeding

253

1363

1.87

19.36

1.5

1.4

6.68

6.25

mmol/l

1.42

237

1253

Infections of the skin and subcutaneous tissue

324

1875

1.73

19.13

1.4

1.3

6.50

6.21

mmol/l

0.92

296

1713

Symptoms and signs involving the urinary system

486

2397

1.57

19.08

1.4

1.3

6.43

6.34

mmol/l

0.29

444

2215

Volume depletion

295

2.96

19.06

1.3

6.77

6.35

mmol/l

0.69

269

Unspecified acute lower respiratory infection

115

460

2.53

18.89

1.3

1.4

6.08

6.40

mmol/l

0.52

105

423

Substance abuse, excluding more controls

354

1841

1.69

18.89

1.3

1.4

6.16

6.25

mmol/l

0.23

322

1711

Injuries to the head

626

2739

1.49

18.80

1.3

6.46

6.25

mmol/l

0.85

574

2535

Fungal Sepsis

110

4.39

18.63

1.4

1.3

6.88

6.35

mmol/l

0.47

104

Emphysema

258

3.08

18.48

1.4

6.38

6.50

mmol/l

0.10

241

Benign neoplasm: Ascending colon

300

2.90

18.48

1.7

1.4

6.69

6.74

mmol/l

0.05

268

Used for control exclusion in common control thyroid runs

617

2082

1.51

18.41

1.4

1.3

6.55

6.08

mmol/l

3.44

567

1912

Other retinal disorders

428

2152

1.61

18.40

1.4

1.3

7.44

6.23

mmol/l

10.12

403

1990

Type 2 diabetes, definitions combined, including avohilmo

548

2121

1.53

18.38

1.3

7.45

5.54

mmol/l

30.97

507

1954

Autoimmune diseases

647

2223

1.49

18.37

1.4

1.3

6.59

6.11

mmol/l

3.26

597

2043

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

585

2545

1.50

18.08

1.4

1.3

6.20

6.33

mmol/l

0.55

547

2345

Misadventures to patients during surgical and medical care

108

430

2.54

17.96

1.6

1.4

6.66

6.35

mmol/l

0.51

397

Bacterial intestinal infections, IBD co-morbidities

138

615

2.27

17.82

1.5

1.4

6.82

6.44

mmol/l

0.74

124

566

Other diseases of the digestive system

246

1350

1.84

17.80

1.5

1.4

6.67

6.24

mmol/l

1.41

231

1241

Cough

211

1056

1.93

17.70

1.4

1.3

6.07

6.19

mmol/l

0.26

198

965

Stroke, including SAH

438

2054

1.59

17.67

1.4

6.97

6.24

mmol/l

4.48

410

1891

Other (not insulin) diabetes medications

563

2257

1.51

17.55

1.4

1.3

7.77

5.59

mmol/l

37.18

520

2087

234

1259

1.85

17.51

1.3

6.26

6.23

mmol/l

0.06

217

1147

Benign neoplasm: Sigmoid colon

107

431

2.50

17.35

1.4

6.68

6.75

mmol/l

0.09

387

Diseases of the skin and subcutaneous tissue

600

2033

1.48

16.68

1.4

1.3

6.43

6.21

mmol/l

0.89

551

1874

Syncope and collapse

274

1394

1.75

16.68

1.4

6.71

6.24

mmol/l

1.89

254

1291

Mental and behavioural disorders due to alcohol, excluding acute intoxication

290

1700

1.71

16.66

1.3

6.10

6.27

mmol/l

0.42

264

1563

Substance abuse

354

2089

1.63

16.58

1.3

6.16

6.27

mmol/l

0.28

322

1926

Biguanides

562

2333

1.49

16.58

1.3

7.79

5.77

mmol/l

31.61

518

2155

Mental and behavioural disorders due to psychoactive substance use

361

2115

1.62

16.50

1.3

6.17

6.27

mmol/l

0.22

329

1952

Other soft tissue disorders, not elsewhere classified

528

2172

1.51

16.47

1.3

6.46

6.24

mmol/l

0.92

490

2003

Acute peritonitis

208

3.18

16.34

1.5

1.4

6.94

6.44

mmol/l

0.45

196

Idiopathic gout

380

2.57

16.28

1.6

1.4

6.11

6.41

mmol/l

0.54

353

Benign neoplasm: Rectum, anus and anal canal

114

487

2.36

16.28

1.4

6.48

6.71

mmol/l

0.45

104

442

Coagulation defects, purpura and other haemorrhagic conditions

133

607

2.21

16.26

1.4

6.10

6.38

mmol/l

0.44

125

562

Other disorders of glucose regulation and pancreatic internal secretion

240

3.00

16.21

1.3

1.4

8.54

6.49

mmol/l

3.92

223

Alcoholic liver disease

352

2.62

16.15

1.4

6.63

6.21

mmol/l

0.55

323

Stroke, excluding SAH

419

1997

1.57

16.11

1.3

1.4

7.04

6.23

mmol/l

4.99

391

1845

Osteopathies and chondropathies

319

1834

1.66

16.09

1.4

1.3

6.62

6.39

mmol/l

0.69

291

1688

Myocardial infarction, without ST-elevation

315

1756

1.67

16.08

1.3

1.4

7.07

6.23

mmol/l

4.88

293

1618

Non-follicular lymphoma

359

2.60

16.05

1.5

1.4

6.09

6.51

mmol/l

0.74

335

Other disorders of kidney and ureter

106

445

2.41

15.81

1.5

1.4

6.76

6.43

mmol/l

0.50

414

Symptoms and signs involving the digestive system and abdomen

605

2076

1.46

15.77

1.4

1.3

6.39

6.27

mmol/l

0.43

553

1922

Intestinal stricture

217

1192

1.83

15.73

1.3

1.4

6.18

6.42

mmol/l

0.58

199

1089

L04AX Other immunosuppressants

294

1759

1.68

15.71

1.4

1.3

5.88

6.35

mmol/l

1.91

269

1626

318

2.66

15.52

1.3

1.4

6.16

6.31

mmol/l

0.21

297

Other cataract

288

1320

1.70

15.43

1.4

6.94

6.13

mmol/l

3.45

272

1220

Ischaemic Stroke, excluding all haemorrhages

402

1953

1.56

15.41

1.3

1.4

7.08

6.24

mmol/l

5.23

377

1807

Second line medication for Crohn's disease

298

1803

1.66

15.27

1.4

1.3

5.89

6.34

mmol/l

1.83

272

1667

Benign neoplasm: Colon

354

2189

1.59

15.26

1.4

6.92

6.29

mmol/l

2.93

320

2040

Nonischemic cardiomyopathy

166

3.37

15.22

1.3

5.74

6.27

mmol/l

0.69

151

Diabetic retinopathy, excluding more controls

173

482

2.04

15.22

1.4

1.3

9.37

6.94

mmol/l

11.51

164

447

Gastroduodenal ulcer

209

1145

1.83

15.18

1.4

1.3

6.63

6.40

mmol/l

0.52

192

1054

Use of hypnotics and sedatives

614

2473

1.44

15.12

1.3

6.38

6.25

mmol/l

0.49

559

2294

Fracture of femur

204

1019

1.84

14.81

1.2

1.4

6.63

6.47

mmol/l

0.32

190

934

Hydronephrosis

338

2.57

14.78

1.3

1.4

6.17

6.18

mmol/l

0.01

312

Pain, not elsewhere classified

141

684

2.07

14.74

1.3

1.4

6.26

6.29

mmol/l

0.04

126

625

All influenza (not pneumonia)

287

2.70

14.66

1.4

1.3

6.38

6.12

mmol/l

0.34

269

Early onset COPD

156

788

2.00

14.64

1.3

1.4

6.52

6.32

mmol/l

0.30

146

722

Sequelae of external causes of morbidity and mortality

163

837

1.96

14.58

1.4

1.3

6.90

6.34

mmol/l

1.51

151

767

Asthma, including avohilmo

656

2707

1.41

14.55

1.4

1.3

6.30

6.28

mmol/l

0.08

604

2503

Mental and behavioural disorders due to alcohol

316

1914

1.61

14.47

1.3

6.14

6.27

mmol/l

0.32

289

1765

Benign neoplasm: Rectum

423

2.36

14.20

1.4

6.52

6.72

mmol/l

0.35

382

Paralytic ileus and intestinal obstruction

182

980

1.87

14.10

1.3

1.4

6.06

6.37

mmol/l

0.71

167

895

Malignant neoplasm of breast

232

954

1.76

14.07

1.3

6.38

6.52

mmol/l

0.34

217

892

Malignant neoplasm of breast, HER2-negative

227

947

1.77

14.00

1.3

6.35

6.53

mmol/l

0.47

213

885

Hypotension

137

672

2.06

14.00

1.4

6.49

6.42

mmol/l

0.09

128

614

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

284

2.68

13.96

1.5

1.4

6.99

6.69

mmol/l

0.30

269

Colorectal cancer, excluding all cancers (controls excluding all cancers)

155

767

1.97

13.94

1.3

1.4

6.57

6.63

mmol/l

0.10

145

699

Agranulocytosis

332

2.53

13.79

1.3

1.4

5.86

6.45

mmol/l

1.08

315

Injuries to the hip and thigh

305

1749

1.60

13.51

1.4

6.36

6.38

mmol/l

0.05

286

1606

Purpura and other haemorrhagic conditions

433

2.31

13.51

1.4

5.87

6.51

mmol/l

1.18

402

Nausea and vomiting

158

810

1.93

13.50

1.3

6.37

6.40

mmol/l

0.04

147

735

Convulsions, not elsewhere classified

124

589

2.09

13.28

1.3

1.4

6.66

6.16

mmol/l

1.03

112

538

Malignant neoplasm of skin

422

2134

1.50

13.26

1.4

6.34

6.38

mmol/l

0.09

394

1973

Alcohol use disorder, ICD-based

260

1579

1.65

13.26

1.3

1.4

6.18

6.26

mmol/l

0.17

235

1448

Angina pectoris

375

1653

1.54

13.23

1.4

7.00

6.07

mmol/l

7.00

348

1522

Fentanyl

315

2.53

13.21

1.5

1.4

5.59

6.53

mmol/l

2.22

285

Chronic pancreatitis

401

2.34

13.14

1.4

7.23

6.29

mmol/l

1.39

367

Exposure to unspecified factor

519

2822

1.43

13.11

1.3

6.49

6.26

mmol/l

0.95

481

2607

Polyneuropathies and other disorders of the peripheral nervous system

158

836

1.91

13.01

1.4

6.83

6.30

mmol/l

1.24

146

760

Hypoglycaemia, other or unspecified

190

2.99

12.79

1.4

1.3

8.46

6.41

mmol/l

3.53

179

Aortic aneurysm

185

1016

1.80

12.77

1.4

6.04

6.09

mmol/l

0.09

169

944

Genitourinary diseases

351

1125

1.57

12.75

1.4

1.3

6.53

5.82

mmol/l

3.34

323

1037

Amiodarone users

420

2.29

12.72

1.3

1.4

6.95

6.46

mmol/l

0.88

393

Osteomyelitis

213

2.86

12.67

1.5

1.4

8.46

6.41

mmol/l

3.86

200

Sub-endpoint used in defining T1D endpoints

184

1014

1.79

12.55

1.3

9.92

6.07

mmol/l

24.77

168

929

Benign neoplasm of other and ill-defined parts of digestive system

384

2.33

12.54

1.3

6.65

6.82

mmol/l

0.24

343

Constipation

510

2570

1.43

12.49

1.3

6.43

6.32

mmol/l

0.39

470

2374

Rheumatoid arthritis

212

1123

1.72

12.48

1.4

1.3

5.93

6.38

mmol/l

1.26

192

1037

Other malignant neoplasms of skin (=non-melanoma skin cancer)

378

1990

1.51

12.45

1.4

6.28

6.38

mmol/l

0.25

353

1842

Other diseases of intestines

563

2337

1.40

12.21

1.4

1.3

6.36

6.25

mmol/l

0.34

515

2154

Asthma, hospital admissions , main diagnosis only

436

2699

1.45

12.16

1.4

1.3

6.38

6.27

mmol/l

0.33

399

2501

Presence of other functional implants

359

1680

1.52

12.12

1.4

1.3

6.79

6.18

mmol/l

3.24

341

1545

Gastrointestinal diseases

305

957

1.60

12.10

1.4

1.3

6.28

6.03

mmol/l

0.75

284

884

Cellulitis

136

702

1.95

12.08

1.4

1.3

6.47

6.29

mmol/l

0.27

120

645

Coronary angioplasty

268

1278

1.62

12.06

1.4

6.99

6.06

mmol/l

6.15

244

1176

Sulfasalazine

151

807

1.88

12.05

1.4

1.3

5.76

6.37

mmol/l

1.70

138

742

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

160

873

1.84

11.99

1.3

1.4

5.99

6.43

mmol/l

0.87

140

808

Basal cell carcinoma

382

2052

1.49

11.97

1.4

6.26

6.38

mmol/l

0.36

356

1900

Direct fill therapy

349

2.37

11.94

1.5

1.4

6.77

6.23

mmol/l

0.72

324

Basal cell carcinoma, including avohilmo

388

2068

1.48

11.90

1.3

1.4

6.25

6.40

mmol/l

0.46

361

1916

Retention of urine

253

1320

1.63

11.88

1.4

6.63

6.24

mmol/l

1.33

230

1218

Falls/tendency to fall

592

2139

1.39

11.75

1.4

1.3

6.45

6.20

mmol/l

1.19

551

1964

Obesity related asthma

180

1027

1.76

11.62

1.3

6.86

6.34

mmol/l

1.34

161

945

Intracranial trauma

301

1447

1.56

11.58

1.3

6.34

6.08

mmol/l

0.89

278

1323

Rheumatoid arthritis, including avohilmo

223

1352

1.66

11.53

1.4

1.3

5.95

6.37

mmol/l

1.22

203

1242

Symptoms and signs concerning food and fluid intake

294

2.47

11.49

1.3

1.4

6.00

6.36

mmol/l

0.42

275

Symptoms and signs involving cognition, perception, emotional state and behaviour

531

2680

1.39

11.39

1.3

6.61

6.24

mmol/l

2.26

483

2483

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

249

2.59

11.32

1.5

1.3

5.83

6.79

mmol/l

1.67

225

Other or unspecified ileus, impaction or obstruction

134

705

1.91

11.28

1.3

1.4

6.05

6.42

mmol/l

0.72

121

646

Other complications of surgical and medical care, not elsewhere classified

244

2.61

11.26

1.4

6.26

6.49

mmol/l

0.27

230

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

107

522

2.06

11.17

1.3

1.4

6.52

6.66

mmol/l

0.18

100

473

Unspecified haematuria

283

1561

1.56

11.17

1.4

6.34

6.29

mmol/l

0.11

263

1440

Seropositive rheumatoid arthritis, wide

162

908

1.79

11.15

1.3

1.4

5.97

6.43

mmol/l

0.94

142

841

Benign neoplasms

538

2161

1.39

11.15

1.4

1.3

6.46

6.16

mmol/l

1.40

497

1994

Melanocytic naevi

112

557

2.02

11.07

1.3

6.27

6.69

mmol/l

0.85

104

504

Other/unspecified seropositive rheumatoid arthritis

160

896

1.80

11.05

1.3

1.4

5.99

6.42

mmol/l

0.85

140

830

Seropositive rheumatoid arthritis

162

910

1.79

10.98

1.3

5.97

6.45

mmol/l

1.00

142

832

Persons encountering health services for other counselling and medical advice, not elsewhere classified

594

2488

1.36

10.89

1.4

1.3

6.53

6.22

mmol/l

1.63

553

2300

L02BG Aromatase inhibitors

139

749

1.87

10.88

1.3

6.33

6.52

mmol/l

0.44

130

704

Reimbursement for rheumatic diseases

305

2012

1.52

10.88

1.3

5.99

6.35

mmol/l

1.32

277

1856

Seropositive rheumatoid arthritis, strict definition

449

2.13

10.81

1.3

1.4

5.79

6.38

mmol/l

0.76

420

In situ neoplasms

220

1355

1.63

10.74

1.3

1.4

6.63

6.37

mmol/l

0.52

213

1238

Pneumococcal septicemia

3.65

10.68

1.3

1.4

6.00

6.37

mmol/l

0.31

Viral infections characterized by skin and mucous membrane lesions

212

1296

1.64

10.61

1.4

1.3

6.34

6.35

mmol/l

0.03

196

1181

Diverticular disease of intestine

433

2026

1.42

10.52

1.4

1.3

6.40

6.35

mmol/l

0.14

400

1869

Medicines for HER+ breast cancer

162

900

1.76

10.49

1.3

6.30

6.52

mmol/l

0.55

151

841

Other disorders of teeth and supporting structures

130

695

1.88

10.46

1.5

1.4

6.00

6.37

mmol/l

0.72

117

647

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

225

2.61

10.38

1.5

1.4

6.88

6.58

mmol/l

0.28

211

Diseases of peritoneum

334

2.30

10.38

1.4

7.06

6.44

mmol/l

0.74

311

Acute pancreatitis

129

693

1.87

10.25

1.3

1.4

7.01

6.24

mmol/l

1.59

119

632

Factors influencing health status and contact with health services

185

533

1.75

10.24

1.4

1.3

6.54

6.04

mmol/l

1.38

171

486

Congenital malformations, deformations and chromosomal abnormalities

253

1558

1.56

10.23

1.4

1.3

6.22

6.23

mmol/l

0.02

238

1427

Disorders of thyroid, IBD co-morbidities

342

2.10

10.14

1.5

1.2

6.27

5.39

mmol/l

3.73

317

Injuries to the thorax

267

1747

1.53

10.06

1.4

1.3

6.22

6.35

mmol/l

0.30

250

1593

Mycoses

152

864

1.77

10.03

1.4

6.44

6.32

mmol/l

0.20

141

794

Hernia

504

2497

1.37

9.95

1.4

1.3

6.29

6.34

mmol/l

0.17

466

2306

Diagnoses used for exclusion with ILD

168

987

1.71

9.88

1.4

6.88

6.35

mmol/l

1.49

157

898

Sequelae with surgical and medical care as external cause

125

674

1.87

9.84

1.4

7.03

6.40

mmol/l

1.56

116

620

Dermatitis

325

2227

1.46

9.78

1.4

1.3

6.30

6.38

mmol/l

0.19

298

2053

Persons encountering health services in other circumstances

189

1147

1.65

9.78

1.3

6.60

6.19

mmol/l

1.09

178

1051

Other arthritis (FG)

174

1035

1.69

9.76

1.4

1.3

6.11

6.39

mmol/l

0.69

163

951

Covid-19 suspected case

448

2.06

9.71

1.5

1.4

6.62

6.23

mmol/l

0.65

416

Other and unspecified polyneuropathies, also in other diseases

134

742

1.82

9.70

1.4

6.88

6.35

mmol/l

1.06

125

676

Drug-induced neutropenia

204

2.63

9.67

1.3

1.4

5.60

6.49

mmol/l

1.50

189

Dysphagia

151

870

1.75

9.54

1.4

1.3

6.25

6.35

mmol/l

0.17

143

789

Osteoporosis

156

864

1.73

9.51

1.4

6.52

6.53

mmol/l

0.02

146

803

Certain disorders involving the immune mechanism

111

583

1.92

9.48

1.5

1.3

6.99

6.27

mmol/l

1.75

105

539

Problems related to lifestyle

242

2.46

9.42

1.3

1.4

6.57

6.13

mmol/l

0.49

223

Parodontitis or operation codes

484

2625

1.36

9.25

1.4

1.3

6.20

6.35

mmol/l

0.51

444

2432

Chronic periodontitis, including avohilmo

481

2621

1.36

9.19

1.4

1.3

6.21

6.35

mmol/l

0.45

441

2428

Parodontitis

483

2624

1.36

9.18

1.4

1.3

6.20

6.35

mmol/l

0.51

443

2431

Injuries to the abdomen, lower back, lumbar spine and pelvis

219

1393

1.57

9.14

1.4

5.90

6.43

mmol/l

1.97

204

1273

Open wound of head

294

1979

1.47

9.00

1.4

1.3

6.40

6.28

mmol/l

0.27

272

1822

Contact with and exposure to communicable diseases

106

556

1.90

8.97

1.3

5.87

6.02

mmol/l

0.32

512

Cholelithiasis, broad definition with cholecystitis

478

2423

1.35

8.81

1.3

6.59

6.22

mmol/l

2.05

448

2236

Other disorders of white blood cells

174

2.68

8.73

1.6

1.5

5.96

6.64

mmol/l

0.94

160

Statin medication

338

1317

1.44

8.66

1.4

1.3

6.76

5.70

mmol/l

7.84

310

1210

Benzodiazepine use

527

2828

1.33

8.59

1.3

6.19

6.31

mmol/l

0.46

472

2630

Fracture of rib(s), sternum and thoracic spine

184

1150

1.61

8.58

1.3

1.4

6.09

6.37

mmol/l

0.59

173

1048

Autoimmune diseases related-to ILD

428

2765

1.36

8.57

1.4

1.3

6.32

6.28

mmol/l

0.11

401

2555

Sleep disorders (combined)

519

2556

1.33

8.56

1.3

6.45

6.27

mmol/l

0.67

475

2372

Other specified/unspecified arthritis

153

913

1.68

8.56

1.4

1.3

6.12

6.35

mmol/l

0.47

144

845

DVT of lower extremities

124

699

1.79

8.52

1.2

1.4

6.18

6.36

mmol/l

0.28

116

633

Gastric ulcer

127

721

1.77

8.52

1.4

6.62

6.35

mmol/l

0.57

117

663

Acute pancreatitis (for exclusion)

129

737

1.76

8.46

1.3

1.4

7.01

6.31

mmol/l

1.39

119

684

External causes of morbidity and mortality

360

1270

1.42

8.41

1.5

1.3

6.42

6.18

mmol/l

0.80

341

1161

Finngen Rheumatological endpoints

503

2143

1.34

8.40

1.4

1.3

6.23

6.29

mmol/l

0.16

461

1970

Disorders of other endocrine glands

208

1324

1.55

8.32

1.4

1.3

6.67

6.38

mmol/l

0.68

191

1217

Substance use, excluding alcohol

482

1.94

8.31

1.2

1.4

6.13

6.16

mmol/l

0.02

448

Malignant neoplasm of breast, HER-positive

147

865

1.68

8.21

1.3

6.40

6.53

mmol/l

0.26

136

810

Open wound of lower leg

416

2.01

8.19

1.4

7.02

6.45

mmol/l

0.61

384

Diabetic retinopathy

222

910

1.55

8.18

1.4

9.00

7.47

mmol/l

7.22

209

840

Phlebitis and thrombophlebitis (not including DVT)

127

735

1.74

7.99

1.3

1.4

6.12

6.35

mmol/l

0.38

119

672

Other and unspecified dermatitis

257

1758

1.47

7.92

1.4

1.3

6.29

6.34

mmol/l

0.11

236

1620

Unspecified fall

261

1781

1.46

7.82

1.3

6.27

6.33

mmol/l

0.14

242

1634

Other antidepressants

581

2334

1.30

7.78

1.3

6.50

6.23

mmol/l

1.18

533

2171

Poisoning by drugs, medicaments and biological substances

537

1.85

7.73

1.2

1.4

6.46

6.11

mmol/l

0.52

501

Other external causes of accidental injury

450

1675

1.35

7.66

1.4

1.3

6.51

6.21

mmol/l

1.20

417

1538

Other symptoms and signs involving the urinary system

368

2.03

7.52

1.5

1.4

6.42

mmol/l

0.00

342

Concussion

241

1421

1.47

7.46

1.3

6.15

6.08

mmol/l

0.15

219

1299

Cutaneous abscess, furuncle and carbuncle

128

759

1.69

7.40

1.5

1.3

6.73

6.24

mmol/l

0.88

119

700

Delirium, not induced by alcohol and other psychoactive substances

474

1.89

7.40

1.3

1.4

6.57

6.43

mmol/l

0.17

434

Thoracic aortic aneurysm

518

1.85

7.36

1.4

1.3

5.96

6.21

mmol/l

0.51

476

Use of anticholinesterases

1364

0.56

7.34

1.2

1.4

6.09

6.42

mmol/l

0.59

1268

N06DA Anticholinesterases

1364

0.56

7.34

1.2

1.4

6.09

6.42

mmol/l

0.59

1268

Other special examinations and investigations of persons without complaint or reported diagnosis

389

1442

1.37

7.31

1.4

1.3

6.34

6.10

mmol/l

0.96

358

1332

Unstable angina pectoris

252

1441

1.46

7.31

1.5

1.4

7.03

6.18

mmol/l

3.89

234

1334

Thyrotoxicosis

118

687

1.73

7.30

1.4

6.89

6.46

mmol/l

1.02

110

632

Duodenal ulcer

450

1.90

7.23

1.3

1.4

6.78

6.40

mmol/l

0.47

415

Systemic connective tissue disorders

183

1192

1.54

7.21

1.4

1.3

6.54

6.35

mmol/l

0.35

165

1100

Malignant melanoma, excluding all cancers (controls excluding all cancers)

422

1.93

7.20

1.5

1.4

6.19

6.69

mmol/l

0.59

382

Accidents

446

1675

1.34

7.20

1.4

1.3

6.55

6.21

mmol/l

1.45

416

1538

Other neurological diseases

410

2474

1.34

7.15

1.4

1.3

6.64

6.32

mmol/l

1.71

390

2279

Neurological diseases, wide definition

136

402

1.70

7.06

1.4

1.2

6.15

5.35

mmol/l

3.90

128

369

Other gastritis (incl. Duodenitis)

134

816

1.65

7.04

1.4

1.3

6.39

6.34

mmol/l

0.08

121

741

Lung diseases due to external agents

103

585

1.77

7.00

1.3

1.4

6.65

6.45

mmol/l

0.27

539

Other other unspecified disorders of the circulatory system

113

2.88

6.98

1.3

7.03

6.56

mmol/l

0.41

106

Fracture of lumbar spine and pelvis

132

802

1.65

6.96

1.5

1.4

6.15

6.47

mmol/l

0.54

125

732

Injury, poisoning and certain other consequences of external causes

289

1017

1.43

6.95

1.4

1.3

6.46

6.14

mmol/l

0.80

275

930

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

183

721

1.56

6.95

1.4

6.25

6.49

mmol/l

0.43

155

660

Thyrotoxicosis, other and/or unspecified

513

1.82

6.94

1.5

1.4

6.91

6.42

mmol/l

1.16

469

Benign neoplasm: Stomach

196

2.36

6.87

1.4

1.3

6.52

7.07

mmol/l

0.65

179

Actinic keratosis

250

1663

1.43

6.84

1.4

6.29

6.40

mmol/l

0.19

233

1534

Cholelithiasis

447

2391

1.31

6.84

1.3

6.66

6.23

mmol/l

2.50

418

2209

Parodontitis and operation codes

438

2596

1.31

6.82

1.4

1.3

6.32

6.33

mmol/l

0.02

402

2405

Chronic nephritic syndrome

115

2.82

6.76

1.8

1.3

6.91

6.48

mmol/l

0.23

108

Malignant neoplasm of urinary organs

412

1.91

6.72

1.4

6.39

6.42

mmol/l

0.02

384

Tuberculosis

269

2.14

6.71

1.3

1.4

5.98

6.57

mmol/l

0.73

253

Intracranial injury

295

2067

1.38

6.62

1.3

6.45

6.27

mmol/l

0.54

271

1905

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

543

1.78

6.61

1.2

1.4

6.64

6.67

mmol/l

0.03

496

Arterial embolism and thrombosis

206

2.31

6.61

1.3

7.26

6.53

mmol/l

0.64

192

Poisoning by medicine

471

1.83

6.59

1.2

1.4

6.46

6.17

mmol/l

0.35

438

Sleep apnoea

476

2498

1.29

6.54

1.3

6.49

6.27

mmol/l

0.89

436

2317

Sulfonylureas

254

1432

1.42

6.51

1.4

9.14

5.73

mmol/l

25.46

236

1325

Sequelae of cerebrovascular disease

230

1405

1.44

6.48

1.3

1.4

6.81

6.22

mmol/l

2.27

221

1289

262

1759

1.41

6.48

1.3

1.4

6.33

6.38

mmol/l

0.08

243

1625

Abdominal and pelvic pain

529

2076

1.28

6.43

1.4

1.3

6.39

6.27

mmol/l

0.41

487

1922

Skin changes due to chronic exposure to nonionizing radiation

252

1693

1.41

6.43

1.4

6.30

6.40

mmol/l

0.16

234

1562

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

328

1.99

6.38

1.2

1.3

6.16

6.21

mmol/l

0.04

308

Respiratory tuberculosis

229

2.21

6.36

1.4

1.5

5.83

6.51

mmol/l

0.82

215

Respiratory tuberculosis, confirmed and not-confirmed

229

2.21

6.36

1.4

1.5

5.83

6.51

mmol/l

0.82

215

Diabetic retinopathy, strict definition

114

599

1.68

6.35

1.4

9.99

7.37

mmol/l

10.60

106

545

Other nutritional deficiencies

276

1952

1.38

6.30

1.3

6.77

6.25

mmol/l

2.27

255

1801

Essential (haemorrhagic) thrombocythaemia

3.37

6.29

1.1

1.4

6.98

7.19

mmol/l

0.12

Other benign neoplasms of skin

146

917

1.57

6.25

1.3

6.23

6.70

mmol/l

1.58

137

842

Personality disorders, excluding more controls

523

1.76

6.25

1.2

1.3

6.51

6.16

mmol/l

0.42

486

Other viral diseases

116

701

1.66

6.24

1.3

6.51

6.20

mmol/l

0.41

103

652

Diseases of the eye and adnexa

386

1453

1.33

6.21

1.4

1.3

6.32

5.95

mmol/l

1.31

354

1342

Leiomyoma of uterus

132

456

1.63

6.12

1.3

1.2

6.52

6.78

mmol/l

0.57

119

418

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

101

594

1.70

6.09

1.3

1.4

6.46

6.22

mmol/l

0.32

556

Pain (limb, back, neck, head abdominally)

421

1612

1.31

6.04

1.4

1.3

6.44

6.15

mmol/l

1.14

388

1487

Noninfective enteritis and colitis

217

1521

1.43

5.97

1.3

6.65

6.27

mmol/l

1.07

201

1391

Transient ischemic attack

314

1938

1.35

5.91

1.4

6.73

6.24

mmol/l

2.66

296

1793

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

177

707

1.51

5.89

1.4

6.20

6.48

mmol/l

0.51

150

646

Benign neoplasm: Ascending colon

491

1.76

5.82

1.7

1.4

6.69

6.33

mmol/l

0.56

455

Supplementary factors related to causes of morbidity and mortality classified elsewhere

143

931

1.54

5.75

1.4

6.34

6.29

mmol/l

0.06

129

853

Examination and observation for other reasons

313

1414

1.35

5.69

1.4

1.3

6.24

6.09

mmol/l

0.38

293

1308

Embolic stroke with flimmer

3.07

5.67

1.4

1.3

8.55

6.30

mmol/l

1.23

Volvulus

2.92

5.65

1.3

5.97

7.19

mmol/l

1.40

Fracture of lower leg, including ankle

264

1930

1.37

5.60

1.3

6.64

6.30

mmol/l

1.07

241

1779

Tuberculosis, IBD comorbidity

303

1.97

5.59

1.4

5.91

6.66

mmol/l

1.08

286

Chronic gastritis

166

1123

1.48

5.59

1.3

6.27

6.41

mmol/l

0.27

159

1033

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

310

1.95

5.58

1.5

1.4

5.97

6.42

mmol/l

0.72

287

Soft tissue disorders

529

2190

1.26

5.54

1.4

1.3

6.42

6.24

mmol/l

0.74

481

2019

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

144

952

1.52

5.42

1.4

1.3

6.63

6.30

mmol/l

0.91

132

883

Sleep apnoea, including avohilmo

489

2527

1.26

5.38

1.3

6.46

6.26

mmol/l

0.79

451

2344

Other noninfective gastroenteritis and colitis

118

747

1.58

5.38

1.2

1.4

6.78

6.30

mmol/l

0.89

106

690

Degeneration of macula and posterior pole

289

1780

1.34

5.38

1.4

6.58

6.24

mmol/l

1.17

274

1643

Type of accident

132

860

1.54

5.33

1.4

6.28

6.31

mmol/l

0.04

119

790

Chronic diseases of tonsils and adenoids

197

1755

0.71

5.28

1.3

5.98

6.33

mmol/l

1.16

186

1623

Other skin changes

597

1.65

5.27

1.3

1.4

6.59

6.46

mmol/l

0.20

556

Other functional intestinal disorders

232

1605

1.38

5.26

1.4

1.3

6.44

6.34

mmol/l

0.20

212

1478

Insulin, fast-acting (human)

375

1.82

5.19

1.4

1.3

10.90

5.77

mmol/l

14.82

347

Exclusions for E4_PCOS_CONSORTIUM

267

1234

1.36

5.17

1.2

1.3

6.25

6.36

mmol/l

0.27

240

1152

Tuberculosis, wide

313

1.90

5.12

1.4

5.91

6.62

mmol/l

1.01

294

Abnormal serum enzyme levels

196

1376

1.41

5.09

1.3

1.4

6.34

6.23

mmol/l

0.21

177

1271

Other disorders of skin and subcutaneous tissue, not elsewhere classified

476

1.71

5.00

1.4

7.58

6.36

mmol/l

2.12

442

Abnormalities of gait and mobility

455

1.73

4.96

1.3

1.4

7.01

6.53

mmol/l

0.69

426

Other disorders of veins

181

1275

1.42

4.95

1.3

6.01

6.39

mmol/l

1.09

172

1165

Idiopathic pulmonary fibrosis

324

1.87

4.95

1.5

1.4

6.20

6.52

mmol/l

0.34

305

Specific personality disorders

493

1.69

4.92

1.3

6.58

6.11

mmol/l

0.60

458

Other infectious diseases

275

1.94

4.92

1.7

1.4

6.20

6.66

mmol/l

0.54

256

Tubulo-interstitial nephritis, not specified as acute or chronic

187

2.15

4.91

1.5

1.4

7.88

6.30

mmol/l

1.95

172

Non-Hodgkin lymphoma, all

168

2.23

4.90

1.6

1.4

5.58

6.49

mmol/l

1.26

162

Benign neoplasm: Colon, unspecified

148

1008

1.48

4.89

1.4

6.76

6.37

mmol/l

0.94

128

917

Alcohol dependence

150

1024

1.47

4.89

1.3

1.4

6.28

6.26

mmol/l

0.03

134

937

Malignant neoplasm of digestive organs

239

1742

1.36

4.87

1.3

1.4

6.34

6.30

mmol/l

0.06

222

1601

Carcinoma in situ of skin of scalp and neck

3.12

4.82

1.4

1.3

6.02

7.49

mmol/l

0.74

Benign neoplasm: Sigmoid colon

107

683

1.57

4.79

1.4

6.68

6.35

mmol/l

0.63

631

Other local infections of skin and subcutaneous tissue

292

1.90

4.77

1.5

1.4

6.51

6.40

mmol/l

0.09

272

Hernia of abdominal wall

235

1742

1.35

4.77

1.3

6.64

6.33

mmol/l

0.86

218

1594

Benign neoplasm: Rectosigmoid junction

2.70

4.76

1.2

1.4

6.89

7.24

mmol/l

0.18

Other reaction to severe stress, and adjustment disorders

124

819

1.52

4.74

1.4

1.3

6.42

6.21

mmol/l

0.39

114

753

Complications of internal orthopaedic prosthetic devices, implants and grafts

122

806

1.52

4.69

1.4

1.3

6.85

6.37

mmol/l

0.98

117

735

Systemic lupus erythematosus, unspecified

3.05

4.68

1.5

1.2

7.44

6.99

mmol/l

0.20

Other and unspecified local infections of skin and subcutaneous tissue

273

1.92

4.68

1.5

1.4

6.48

6.43

mmol/l

0.04

254

Psychiatric diseases

561

2299

1.22

4.67

1.3

6.34

6.30

mmol/l

0.12

510

2151

Diseases of the musculoskeletal system and connective tissue

274

1031

1.34

4.61

1.4

1.3

6.30

6.16

mmol/l

0.33

253

953

Abdominal aortic aneurysm (AAA)

499

1.66

4.61

1.4

6.18

6.07

mmol/l

0.14

465

Persons encountering health services for examination and investigation

368

1442

1.28

4.59

1.4

1.3

6.30

6.10

mmol/l

0.61

339

1332

Malignant neoplasm of head and neck

318

1.84

4.58

1.4

1.5

5.95

6.38

mmol/l

0.55

296

Acute upper respiratory infections of multiple and unspecified sites

335

1957

1.28

4.56

1.4

1.3

6.39

6.26

mmol/l

0.34

314

1793

Fracture of shoulder and upper arm

174

1237

1.41

4.56

1.3

6.71

6.40

mmol/l

0.58

161

1134

Disorder of lipoprotein metabolism, unspecified

475

1.67

4.53

1.4

1.3

7.11

6.13

mmol/l

1.78

433

Dizziness and giddiness

378

2438

1.26

4.48

1.4

1.3

6.68

6.27

mmol/l

2.12

347

2261

Missing teeth due to accident, extraction or parodontitis

365

1.76

4.44

1.6

1.4

6.06

6.32

mmol/l

0.34

341

Umbilical hernia

139

955

1.46

4.43

1.2

1.4

6.88

6.26

mmol/l

1.38

128

872

Obesity and other hyperalimentation

252

1893

1.32

4.38

1.3

6.89

6.23

mmol/l

3.01

231

1750

Fracture of foot, except ankle

635

1.56

4.37

1.3

6.43

6.20

mmol/l

0.38

588

Bicuspidal aortic valve syndrome

2.61

4.32

1.3

1.4

6.16

6.45

mmol/l

0.31

Viral and other specified intestinal infections

418

1.69

4.29

1.3

6.51

6.24

mmol/l

0.39

389

Obesity

250

1884

1.32

4.28

1.3

6.90

6.23

mmol/l

3.06

229

1741

Personality disorders

584

1.58

4.25

1.3

6.51

6.15

mmol/l

0.44

538

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

101

656

1.54

4.23

1.3

6.46

6.11

mmol/l

0.55

608

Disorders of adult personality and behaviour

609

1.56

4.21

1.3

6.48

6.14

mmol/l

0.42

562

Colectomy operation

627

1.55

4.17

1.2

1.4

6.71

6.38

mmol/l

0.48

584

Episodal and paroxysmal disorders

551

2337

1.21

4.17

1.3

6.38

6.19

mmol/l

0.79

498

2156

Acute sinusitis

206

1426

1.35

4.15

1.3

6.03

6.22

mmol/l

0.35

189

1311

Other diseases of liver

518

1.61

4.14

1.4

6.63

6.34

mmol/l

0.44

482

Parodontitis or/and operation codes

279

1275

1.30

4.14

1.3

6.30

6.19

mmol/l

0.25

254

1195

Diaphragmatic hernia

189

1390

1.36

4.11

1.4

6.21

6.33

mmol/l

0.24

171

1277

Diseases of pulp and periapical tissues, including avohilmo

555

2393

1.21

4.10

1.3

6.26

6.30

mmol/l

0.09

514

2212

Other diseases of arteries and capillaries

272

1.85

4.08

1.3

7.14

6.46

mmol/l

0.84

252

Suicide or other Intentional self-harm

606

1.56

4.08

1.3

6.51

6.16

mmol/l

0.49

562

Dorsalgia

499

2228

1.21

3.99

1.4

1.3

6.46

6.21

mmol/l

1.09

458

2062

Benign neoplasm: Rectum, anus and anal canal

114

771

1.49

3.99

1.4

6.48

6.34

mmol/l

0.28

104

705

Vascular disorders of the intestines

253

1.87

3.98

1.4

6.52

6.63

mmol/l

0.10

236

Procreative management

102

566

1.52

3.95

1.2

1.3

6.17

6.31

mmol/l

0.23

514

Paracetamol of NSAID medication

304

1.58

3.90

1.4

1.3

6.41

6.43

mmol/l

0.02

287

Cardiomyopathies, Secondary/extrinsic

7.49

3.89

1.4

1.5

5.31

6.03

mmol/l

—

Dental pulpitis 1

553

2397

1.20

3.89

1.3

6.29

mmol/l

0.01

511

2216

Injuries to the elbow and forearm

299

2132

1.27

3.88

1.2

1.3

6.46

6.32

mmol/l

0.35

281

1956

Fracture of forearm

232

1662

1.31

3.85

1.2

1.3

6.54

6.34

mmol/l

0.52

220

1535

Superficial injury of head

103

688

1.50

3.83

1.3

1.4

6.41

6.24

mmol/l

0.16

636

Exclusions for E4_PCOS_BROAD

452

1.62

3.78

1.2

1.4

6.45

6.36

mmol/l

0.10

422

Other specified and unspecified personality disorders

187

1.99

3.77

1.2

1.4

5.91

6.25

mmol/l

0.26

172

General examination and investigation of persons without complaint and reported diagnosis

339

1438

1.26

3.74

1.4

1.3

6.54

6.10

mmol/l

2.09

309

1328

Symptoms and signs involving the nervous and musculoskeletal systems

270

2119

1.28

3.71

1.3

6.42

6.29

mmol/l

0.33

254

1953

Methotrexate

393

1.66

3.71

1.3

5.94

6.39

mmol/l

0.46

365

Dental pulpitis 4

551

2399

1.19

3.71

1.3

6.28

6.29

mmol/l

0.02

510

2218

Other and unspecified nonorganic psychotic disorders

409

1.64

3.69

1.2

1.4

5.79

6.17

mmol/l

0.49

384

Weight loss

319

1.73

3.67

1.3

1.4

5.95

6.37

mmol/l

0.44

300

Obesity due to excess calories

181

1348

1.35

3.67

1.3

6.83

6.21

mmol/l

2.20

164

1241

SLE, ICD10

2.63

3.65

1.5

1.2

7.44

6.80

mmol/l

0.32

SLE, strict definition

2.63

3.65

1.5

1.2

7.44

6.80

mmol/l

0.32

Other strabismus

526

1.56

3.64

1.5

1.4

6.11

6.29

mmol/l

0.32

491

Dental caries 2 and operation codes, only avohilmo

182

1509

0.75

3.64

1.3

6.10

6.22

mmol/l

0.24

174

1400

Unspecific neurodegenerative disorder

157

1473

0.73

3.61

1.2

1.4

6.08

6.42

mmol/l

0.89

138

1370

Use of donepezil

916

0.61

3.61

1.2

1.4

5.89

6.52

mmol/l

0.97

845

Noninfectious colitis NAS

390

1.65

3.57

1.2

1.4

7.03

6.49

mmol/l

0.67

366

Dental operations

390

1629

1.23

3.57

1.4

1.3

6.20

6.39

mmol/l

0.70

360

1492

Cardiomyopathy due to drugs and other external agents

10.77

3.56

1.3

1.2

5.62

6.13

mmol/l

—

Cachexia

5.51

3.56

1.6

1.3

6.38

6.94

mmol/l

—

Inguinal hernia

325

1761

1.25

3.51

1.4

1.3

6.15

6.30

mmol/l

0.39

304

1617

Dementia in Alzheimer disease

765

0.60

3.48

1.2

1.4

6.36

6.49

mmol/l

0.15

713

Other anxiety disorders

143

916

1.39

3.48

1.3

6.34

6.22

mmol/l

0.19

127

844

Benign neoplasm: Duodenum

2.92

3.47

1.3

6.69

7.02

mmol/l

0.19

Other symptoms and signs involving cognitive functions and awareness

243

1782

1.28

3.47

1.3

1.4

6.55

6.27

mmol/l

0.81

220

1653

Spondylopathies

420

2105

1.21

3.47

1.3

6.36

6.27

mmol/l

0.23

387

1946

Other viral diseases, not elsewhere classified

470

1.58

3.45

1.3

1.4

5.98

6.25

mmol/l

0.39

439

Any mental disorder

563

2385

1.18

3.43

1.3

6.37

6.30

mmol/l

0.22

510

2230

Systemic lupus erythematosus

2.46

3.39

1.5

1.2

7.47

6.64

mmol/l

0.48

Medical observation and evaluation for suspected diseases and conditions

348

1442

1.24

3.39

1.4

1.3

6.32

6.10

mmol/l

0.68

321

1332

Chronic tubulo-interstitial nephritis

2.46

3.38

1.4

1.3

7.06

6.64

mmol/l

0.40

Alzheimer disease, including avohilmo

131

1306

0.72

3.36

1.3

1.4

6.27

6.41

mmol/l

0.24

111

1222

Benign neoplasm: Rectum

677

1.47

3.35

1.4

6.52

6.35

mmol/l

0.33

625

Other blood glucose lowering drugs, excl. Insulins

621

1.49

3.32

1.4

7.87

5.78

mmol/l

6.81

565

Fluid overload

9.03

3.31

1.2

1.7

7.17

6.76

mmol/l

—

Benign neoplasm: Skin of eyelid, including canthus

314

1.69

3.31

1.3

1.4

6.70

6.80

mmol/l

0.09

284

Disorders of ocular muscles, binocular movement, accommodation and refraction

177

1326

1.33

3.30

1.4

1.3

6.26

6.24

mmol/l

0.02

162

1215

Obesity, other/unspecified

124

889

1.40

3.24

1.4

1.3

6.75

6.24

mmol/l

1.04

112

821

Injuries to the ankle and foot

262

1903

1.26

3.19

1.3

6.56

6.21

mmol/l

1.13

241

1752

Other follicular disorders

151

2.00

3.14

1.3

1.4

6.80

6.40

mmol/l

0.40

138

Dental caries 1

441

1884

1.20

3.14

1.3

6.27

6.34

mmol/l

0.21

401

1735

Cholecystectomy

343

2495

1.22

3.12

1.3

6.73

6.30

mmol/l

1.69

321

2312

Diseases of oral cavity, salivary glands and jaws

483

2090

1.19

3.10

1.4

1.3

6.29

6.33

mmol/l

0.11

439

1931

Schizophrenia or delusion, excluding more controls

114

806

1.41

3.10

1.2

1.3

6.02

6.27

mmol/l

0.38

744

181

1227

1.31

3.08

1.3

1.4

6.75

6.33

mmol/l

1.06

171

1130

Benign neoplasm of other and ill-defined parts of digestive system

607

1.47

3.08

1.3

1.4

6.65

6.43

mmol/l

0.38

564

Other dorsopathies, not elsewhere classified

499

2230

1.18

3.07

1.4

1.3

6.25

6.21

mmol/l

0.12

454

2063

Other and unspecified tonsillitis

101

596

1.44

3.07

1.4

1.3

5.82

6.16

mmol/l

0.58

546

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

552

1.49

3.06

1.4

6.32

6.16

mmol/l

0.18

506

Disorders of parathyroid gland

102

707

1.43

3.03

1.4

6.64

6.48

mmol/l

0.18

652

Dental caries 3

454

1952

1.19

3.03

1.4

1.3

6.22

6.33

mmol/l

0.36

410

1801

Anxiety (asthma-related co-morbidities)

202

1237

1.29

3.02

1.3

6.38

6.20

mmol/l

0.37

181

1150

Dental caries, including avohilmo

439

1884

1.19

3.00

1.3

6.24

6.34

mmol/l

0.30

399

1735

Pneumonitis due to solids and liquids

324

1.65

2.99

1.3

1.4

6.77

6.56

mmol/l

0.17

303

Other systemic involvement of connective tissue (FG)

121

872

1.38

2.98

1.3

6.29

6.49

mmol/l

0.32

110

802

Retinal vascular disorders

482

1.52

2.97

1.5

1.4

6.61

6.34

mmol/l

0.31

443

Dermatophytosis

458

1.54

2.97

1.4

6.20

6.44

mmol/l

0.27

426

Other systemic involvement of connective tissue

126

922

1.37

2.95

1.3

1.4

6.24

6.35

mmol/l

0.18

115

852

Acute suppurative otitis media

442

1.52

2.94

1.3

1.4

5.98

6.05

mmol/l

0.08

407

Temporomandibular joint disorders, including avohilmo

971

0.66

2.89

1.4

1.3

6.09

6.19

mmol/l

0.12

902

Superficial injury of hip and thigh

493

1.51

2.89

1.6

1.4

5.76

6.40

mmol/l

1.74

448

Disorders of skin appendages

177

1367

1.30

2.86

1.5

1.3

6.22

6.26

mmol/l

0.08

168

1249

Combinations of oral blood glucose lowering drugs

145

1091

1.33

2.85

1.3

8.30

5.68

mmol/l

13.36

133

1001

Alzheimer disease

115

1183

0.73

2.82

1.3

1.4

6.33

6.44

mmol/l

0.16

1107

Speech therapy

125

922

1.36

2.81

1.6

1.3

6.63

6.35

mmol/l

0.50

116

847

Heartburn

276

1.67

2.80

1.4

6.85

6.22

mmol/l

0.77

252

Retinal vascular occlusion

473

1.51

2.80

1.5

1.4

6.66

6.35

mmol/l

0.37

436

Other and unspecified effects of external causes

670

1.42

2.78

1.3

1.4

6.92

6.23

mmol/l

1.45

625

Gingivitis and periodontal diseases

467

2051

1.18

2.77

1.3

6.10

6.32

mmol/l

0.94

427

1898

Injury of nerves and spinal cord at thorax level

8.52

2.76

1.4

1.2

7.20

7.28

mmol/l

—

Listeriosis

5.18

2.76

1.6

1.4

6.99

6.13

mmol/l

—

Neurological diseases

413

1751

1.19

2.75

1.4

1.3

6.37

6.15

mmol/l

0.82

377

1617

Palmar fascial fibromatosis [Dupuytren]

101

723

1.40

2.74

1.4

6.89

6.24

mmol/l

0.95

662

Dental caries 3 and operation codes

480

2104

1.17

2.71

1.4

1.3

6.18

6.31

mmol/l

0.47

440

1941

Headache

231

1551

1.25

2.68

1.3

6.63

6.23

mmol/l

1.44

217

1427

Degenerative diseases of the nervous system

132

1317

0.75

2.68

1.3

1.4

6.22

6.41

mmol/l

0.34

113

1224

Barrett oesophagus

161

1.88

2.67

1.3

1.4

5.70

6.53

mmol/l

1.56

152

Infective dermatitis

385

1.54

2.58

1.4

6.34

6.36

mmol/l

0.02

357

Fibroblastic disorders

131

988

1.33

2.58

1.5

1.3

6.77

6.27

mmol/l

0.93

123

906

Other specified/unspecified hearing loss

283

1.63

2.57

1.2

1.4

6.26

6.64

mmol/l

0.57

264

Schizophrenia or delusion

114

842

1.36

2.57

1.2

1.3

6.02

6.31

mmol/l

0.45

778

Dental caries 1 and operation codes

466

2048

1.17

2.56

1.4

1.3

6.14

6.34

mmol/l

0.77

428

1885

Behavioural syndromes associated with physiological disturbances and physical factors

105

766

1.37

2.55

1.2

1.3

6.02

6.15

mmol/l

0.21

713

Schizophrenia, schizotypal and delusional disorders

114

844

1.35

2.53

1.2

1.3

6.03

6.33

mmol/l

0.47

780

Melanocytic naevi

112

828

1.36

2.52

1.3

1.4

6.27

6.30

mmol/l

0.04

104

765

All anxiety disorders

202

1297

1.25

2.51

1.3

6.38

6.22

mmol/l

0.31

181

1199

Benign neoplasm: Choroid

115

2.01

2.51

1.2

1.4

6.79

7.17

mmol/l

0.25

105

Sequelae of injuries, of poisoning and of other consequences of external causes

693

1.39

2.50

1.4

6.26

6.33

mmol/l

0.08

637

Disorders of sclera, cornea, iris and ciliary body

229

1860

1.23

2.49

1.3

6.39

6.31

mmol/l

0.15

207

1714

Panic disorder

247

1.66

2.48

1.3

6.34

6.33

mmol/l

0.00

227

Gastro-oesophageal reflux disease

307

2272

1.20

2.47

1.4

1.3

6.24

6.33

mmol/l

0.17

281

2107

Primary gonarthrosis, bilateral

184

2018

0.80

2.46

1.4

1.3

6.31

6.34

mmol/l

0.06

175

1858

Hyperparathyroidism

621

1.40

2.45

1.4

6.64

6.48

mmol/l

0.18

571

Disorders of the thyroid gland

455

2564

1.16

2.42

1.4

1.3

6.43

6.29

mmol/l

0.51

429

2357

Carcinoma in situ, bladder

2.19

2.42

1.6

1.5

7.31

6.95

mmol/l

0.21

Disorders of eyelid, lacrimal system and orbit

403

2708

1.17

2.40

1.3

6.49

6.31

mmol/l

0.62

376

2503

Postprocedural disorders of digestive system, not elsewhere classified

2.13

2.39

1.3

1.4

6.31

mmol/l

0.00

Dental pulpitis 2

390

1698

1.18

2.39

1.3

6.23

6.36

mmol/l

0.41

361

1562

Leisure time condition

525

1.43

2.35

1.3

1.4

6.66

6.39

mmol/l

0.28

490

Alzheimer’s disease, wide definition

1011

0.73

2.34

1.3

1.4

6.46

6.53

mmol/l

0.08

945

Urticaria and erythema

129

987

1.31

2.32

1.3

6.22

6.32

mmol/l

0.20

115

911

Infections with a predominantly sexual mode of transmission

577

1.40

2.29

1.2

1.3

6.46

6.15

mmol/l

0.40

534

Assault

261

1.61

2.28

1.3

1.4

5.91

6.11

mmol/l

0.16

241

127

921

1.31

2.27

1.3

1.4

6.69

6.35

mmol/l

0.62

121

845

Low back pain

332

2168

1.18

2.26

1.3

6.47

6.23

mmol/l

0.72

302

2006

Injuries to the knee and lower leg

551

2769

1.14

2.25

1.3

6.63

6.22

mmol/l

2.44

508

2562

Unspecified nephritic syndrome

2.30

2.25

1.3

5.91

5.94

mmol/l

0.01

Keratitis

143

1115

1.28

2.25

1.2

1.3

6.45

6.36

mmol/l

0.17

129

1026

Abnormal weight loss

294

1.57

2.25

1.3

1.4

5.98

6.38

mmol/l

0.37

276

Acute bronchiolitis

2.29

2.23

1.2

1.3

5.73

6.18

mmol/l

0.27

Hypothyroidism, strict autoimmune

328

1840

1.18

2.21

1.3

6.34

6.16

mmol/l

0.61

310

1697

Polyuria

112

848

1.32

2.20

1.4

6.25

6.27

mmol/l

0.03

777

Functional dyspepsia

104

779

1.34

2.20

1.3

6.16

6.36

mmol/l

0.33

719

Other and unspecified vascular occlusions

360

1.51

2.19

1.6

1.4

6.48

6.49

mmol/l

0.01

332

Other necrotizing vasculopathies

241

1.63

2.19

1.7

1.4

6.76

6.56

mmol/l

0.14

227

Other disorders of urethra and urinary system

326

2075

1.18

2.18

1.3

6.43

6.29

mmol/l

0.37

300

1923

Hidradenitis suppurativa

2.31

2.15

1.3

1.2

6.34

6.47

mmol/l

0.07

Strabismus

730

1.34

2.13

1.4

6.17

6.31

mmol/l

0.22

674

Myocardial infarction, with ST-elevation

110

836

1.32

2.12

1.4

6.85

6.43

mmol/l

0.90

100

756

Other disorders of ear

447

2595

1.15

2.12

1.4

1.3

6.54

6.30

mmol/l

0.82

420

2391

Dermatitis and eczema

497

2864

1.14

2.07

1.4

1.3

6.13

6.33

mmol/l

0.91

463

2642

Unspecified chronic bronchitis

117

1.89

2.06

1.5

6.11

6.58

mmol/l

0.47

110

Carcinoma in situ of other and unspecified sites

2.04

2.06

1.6

1.4

7.31

6.79

mmol/l

0.34

Superficial injury of abdomen, lower back and pelvis

415

1.45

2.05

1.4

5.27

6.51

mmol/l

3.11

384

Other hearing loss

157

1235

1.25

2.03

1.4

6.47

6.36

mmol/l

0.18

148

1128

Arthropathies

422

1865

1.15

2.03

1.4

1.3

6.28

6.30

mmol/l

0.07

385

1717

Epilepsy

139

1094

1.27

2.02

1.3

1.4

6.29

mmol/l

0.01

125

1005

Other/unspecified dorsalgia

164

1314

1.24

2.01

1.4

1.3

6.03

6.28

mmol/l

0.59

147

1218

Spondyloarthritis

585

1.37

2.00

1.4

6.12

6.35

mmol/l

0.33

541

Alcohol abuse, main dg, excluding more controls

426

1.44

1.99

1.2

1.4

6.45

6.40

mmol/l

0.05

395

Fall on and from stairs and steps

107

819

1.31

1.98

1.4

6.21

6.38

mmol/l

0.22

102

754

Retinal detachments and breaks

178

1451

1.23

1.96

1.4

6.75

6.17

mmol/l

1.77

167

1336

Spinal stenosis

276

1833

1.18

1.96

1.3

6.68

6.29

mmol/l

1.18

261

1695

Antepartum haemorrhage, not elsewhere classified

1.98

1.95

1.1

1.2

5.64

6.21

mmol/l

0.45

Otosclerosis

256

0.47

1.94

1.3

1.5

6.37

6.38

mmol/l

0.01

241

Coxarthrosis [arthrosis of hip](FG)

284

1747

1.18

1.92

1.4

1.3

6.53

6.36

mmol/l

0.46

270

1601

Erythema multiforme

2.26

1.91

1.4

1.3

6.47

6.51

mmol/l

0.03

Dental pulpitis 2, only avohilmo

393

1748

1.15

1.90

1.4

1.3

6.27

6.36

mmol/l

0.28

364

1609

Ulcer of oesophagus

267

1.54

1.89

1.5

1.4

6.39

6.51

mmol/l

0.10

249

Embolic stroke

204

1.63

1.89

1.3

1.4

7.60

6.32

mmol/l

0.90

192

Symptoms and signs involving the skin and subcutaneous tissue

296

2526

1.17

1.88

1.3

6.13

6.33

mmol/l

0.79

280

2328

Dental caries 2, only avohilmo

192

1829

0.83

1.87

1.3

6.14

6.27

mmol/l

0.28

182

1684

Alzheimer’s disease (Late onset)

956

0.75

1.87

1.3

1.4

6.48

6.52

mmol/l

0.04

892

Retained placenta and membranes, without haemorrhage

224

0.45

1.85

1.2

1.3

5.79

6.28

mmol/l

—

205

Migraine, single triptan purchase ok & required. ICD-code if available is included

182

1493

0.82

1.81

1.2

1.3

5.76

6.29

mmol/l

2.37

170

1388

Triptan medication for migraine, single purchase ok

182

1493

0.82

1.81

1.2

1.3

5.76

6.29

mmol/l

2.37

170

1388

Benign neoplasm of bone and articular cartilage

130

1.77

1.81

1.4

1.3

4.82

6.61

mmol/l

1.79

117

Other diseases of anus and rectum

140

1124

1.25

1.79

1.3

6.31

6.35

mmol/l

0.07

129

1029

Use of other anti-dementia drugs

100

1121

0.77

1.79

1.2

1.4

6.34

6.42

mmol/l

0.11

1047

Use of memantine

100

1121

0.77

1.79

1.2

1.4

6.34

6.42

mmol/l

0.11

1047

Granulomatous disorders of skin and subcutaneous tissue

2.18

1.78

2.2

1.2

6.41

6.17

mmol/l

0.10

Benign neoplasm: Skin of scalp and neck

2.45

1.76

1.3

1.2

5.50

6.87

mmol/l

—

Other and unspecified disorders of vitreous body

121

1508

0.80

1.74

1.3

1.4

6.46

6.30

mmol/l

0.23

116

1391

Fall involving bed

110

1.83

1.73

1.2

1.4

7.74

6.66

mmol/l

0.67

105

Biological medication for rheuma

330

1.46

1.73

1.4

5.73

6.17

mmol/l

0.42

304

Cholera

110

1.83

1.73

1.6

1.4

5.77

6.54

mmol/l

0.62

102

Previous suicide attempt

3.88

1.72

1.4

1.1

7.00

6.75

mmol/l

—

Sleep disorders

550

1.35

1.72

1.2

1.4

5.96

6.30

mmol/l

0.61

512

Chronic sinusitis

174

1439

1.21

1.70

1.5

1.3

6.11

6.39

mmol/l

0.81

162

1330

Carcinoma in situ of skin of trunk

2.02

1.70

1.3

5.83

7.73

mmol/l

1.31

Inflammatory bowel disease

118

937

1.26

1.69

1.4

6.54

6.26

mmol/l

0.48

113

865

Use of biperiden

141

1.71

1.68

1.1

1.4

4.95

6.59

mmol/l

2.52

129

Other and unspecified injuries of head

172

1.64

1.67

1.3

6.82

6.59

mmol/l

0.16

159

Disorders of refraction and accommodation

629

1.32

1.66

1.3

6.37

6.25

mmol/l

0.16

581

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

223

1853

1.18

1.65

1.4

1.3

5.80

6.33

mmol/l

2.24

206

1707

Habit and impulse disorders

2.82

1.65

1.4

1.2

5.63

6.22

mmol/l

—

Psoriasis

117

932

1.26

1.64

1.4

1.3

6.22

6.36

mmol/l

0.30

109

858

Schizophrenia

419

1.39

1.62

1.1

1.4

6.15

6.27

mmol/l

0.09

388

Other diseases of urinary system

488

2457

1.12

1.58

1.4

1.3

6.34

6.28

mmol/l

0.15

451

2267

Myeloid leukaemia

1.90

1.55

1.6

1.4

6.28

6.53

mmol/l

0.17

Unspecified mental disorder

144

1182

1.22

1.55

1.2

1.3

6.19

6.29

mmol/l

0.13

127

1091

Benign neoplasm: Rectosigmoid junction

145

1.67

1.54

1.2

1.4

6.89

6.62

mmol/l

0.16

137

Carcinoma in situ of breast, intraductal

100

1.80

1.53

1.2

1.3

6.54

7.01

mmol/l

0.22

Hyperfunction of pituitary gland

1.87

1.50

1.2

5.14

6.57

mmol/l

1.60

Kela-code for severe mental illness

131

1070

1.23

1.50

1.2

1.3

6.04

6.31

mmol/l

0.46

114

987

Other sleep disorders

358

1.40

1.50

1.2

1.4

5.96

6.36

mmol/l

0.48

333

Other disorders of bone

512

1.33

1.49

1.4

5.91

6.25

mmol/l

0.52

476

Lichen simplex chronicus

101

1.79

1.49

1.5

1.3

5.37

6.67

mmol/l

1.29

Soft tissue disorders related to use, overuse and pressure

115

927

1.24

1.49

1.4

1.3

6.39

6.24

mmol/l

0.25

106

852

Anxiety disorders, excluding more controls

327

1906

1.14

1.47

1.3

6.31

6.30

mmol/l

0.02

300

1776

Neurotic, stress-related and somatoform disorders

335

2099

1.14

1.47

1.3

6.27

6.26

mmol/l

0.03

305

1943

Conductive and sensorineural hearing loss

397

2449

1.12

1.46

1.3

6.68

6.31

mmol/l

1.46

376

2254

Acute upper respiratory infections

483

2723

1.11

1.46

1.4

1.3

6.45

6.28

mmol/l

0.55

449

2516

Fracture at wrist and hand level

126

1028

1.23

1.46

1.4

1.3

6.54

6.23

mmol/l

0.38

115

937

Spirochaetal infections, other/unspecified

254

0.55

1.45

1.2

1.4

6.90

6.53

mmol/l

0.31

238

Early complications of trauma

117

1.72

1.45

1.3

6.85

6.64

mmol/l

0.10

110

!Aliquae complicationes praecoces traumatis

117

1.72

1.45

1.4

1.3

6.85

6.64

mmol/l

0.10

110

Bronchitis, not specified as acute or chronic

252

1.47

1.45

1.4

6.63

6.48

mmol/l

0.13

234

Nonorganic sleeping disorders, excluding more controls

429

1.35

1.44

1.2

1.4

5.99

6.30

mmol/l

0.41

402

Gonarthrosis, primary, with knee surgery

228

2153

0.86

1.41

1.4

6.34

6.33

mmol/l

0.01

216

1982

Benign neoplasm: Stomach

329

1.40

1.4

6.52

6.66

mmol/l

0.14

312

Orchitis and epididymitis

346

1.39

1.40

1.4

6.58

6.21

mmol/l

0.32

320

Family history of malignant neoplasm

205

1.52

1.40

1.2

1.3

6.04

6.16

mmol/l

0.10

192

Conjunctivitis (acute, non atopic)

727

1.26

1.39

1.3

6.37

6.35

mmol/l

0.03

665

Superficial injury of ankle and foot

238

1.47

1.39

1.3

1.4

7.28

6.34

mmol/l

0.75

220

Fissure and fistula of anal and rectal regions

100

802

1.25

1.38

1.3

6.24

6.36

mmol/l

0.20

733

Radiculopathy

616

1.29

1.37

1.2

1.4

6.51

6.32

mmol/l

0.23

573

Erectile dysfunction

408

1.35

1.36

1.3

1.4

6.51

6.27

mmol/l

0.23

379

Benign neoplasm: Duodenum

1.84

1.36

1.3

6.69

6.34

mmol/l

0.28

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

2.96

1.36

1.2

5.40

7.59

mmol/l

—

Dental caries 1, only avohilmo

431

1979

1.11

1.35

1.3

6.26

6.35

mmol/l

0.27

388

1825

Fracture of skull and facial bones

636

1.28

1.34

1.2

1.4

6.01

6.17

mmol/l

0.22

587

Shoulder lesions

371

2027

1.12

1.34

1.3

6.25

6.29

mmol/l

0.10

337

1870

Diseases of inner ear

185

2114

0.86

1.33

1.3

1.4

6.67

6.37

mmol/l

0.74

173

1952

Alzheimer disease, excluding more controls

596

0.77

1.33

1.2

1.4

6.58

6.24

mmol/l

0.51

552

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

718

1.26

1.31

1.5

1.3

7.86

5.70

mmol/l

7.07

655

Benign neoplasm: Long bones of lower limb

2.10

1.30

1.2

5.69

6.85

mmol/l

—

Acute alcohol intoxication

116

953

1.22

1.30

1.2

1.4

6.49

6.31

mmol/l

0.25

105

869

Disorders of lacrimal system

167

1419

1.18

1.30

1.3

6.66

6.32

mmol/l

0.82

155

1307

Acute appendicitis, with complications

676

1.26

1.28

1.5

1.4

6.75

6.31

mmol/l

0.55

630

Acute and transient psychotic disorders

276

1.42

1.28

1.3

1.4

6.30

6.38

mmol/l

0.06

259

Varicose veins

298

1995

1.13

1.26

1.4

1.3

6.16

6.36

mmol/l

0.73

279

1843

Colorectal cancer

119

984

1.21

1.26

1.3

1.4

6.57

6.38

mmol/l

0.27

111

898

Anxiety disorders

339

2147

1.12

1.24

1.3

6.27

mmol/l

0.01

309

1987

Vitamin deficiency

139

1.59

1.23

1.1

1.4

7.04

6.59

mmol/l

0.39

130

Vitamin deficiency, wide

139

1.59

1.23

1.1

1.4

7.04

6.59

mmol/l

0.39

130

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

2.17

1.21

1.1

1.2

6.56

7.40

mmol/l

—

Maltreatment syndromes

1.80

1.21

1.1

1.2

5.90

6.56

mmol/l

—

Visual disturbances and blindness

212

1848

1.15

1.20

1.3

1.4

6.41

6.33

mmol/l

0.19

201

1697

Alcohol abuse, main dg

470

1.30

1.19

1.2

1.4

6.45

6.27

mmol/l

0.19

435

Hyperplasia of prostate

229

1140

1.15

1.19

1.4

6.35

6.18

mmol/l

0.37

209

1052

Dentofacial anomalies [including malocclusion]

642

0.75

1.18

1.5

1.3

6.26

6.20

mmol/l

0.06

600

Status epilepticus

117

1.63

1.18

1.2

1.4

6.48

6.77

mmol/l

0.15

109

Coxarthrosis

261

1563

1.13

1.18

1.4

1.3

6.54

6.40

mmol/l

0.36

247

1439

Dental operations, only avohilmo

388

1792

1.11

1.17

1.4

1.3

6.23

6.40

mmol/l

0.57

353

1646

Hypothyroidism, other/unspecified

396

2365

1.11

1.16

1.3

6.36

6.28

mmol/l

0.25

372

2179

Deep bite

174

0.55

1.16

1.3

1.4

5.83

6.24

mmol/l

0.34

159

102

1.67

1.16

1.3

1.2

5.64

6.17

mmol/l

0.54

Non-selective monoamine reuptake inhibitors

170

1420

1.16

1.15

1.3

1.4

6.43

6.32

mmol/l

0.16

156

1312

Ventral hernia

104

859

1.21

1.14

1.4

1.3

6.39

6.36

mmol/l

0.04

776

Dementia, including avohilmo

203

1603

0.87

1.14

1.3

1.4

6.10

6.43

mmol/l

0.91

182

1488

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

1.86

1.13

1.2

1.3

6.03

7.64

mmol/l

1.04

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

234

0.60

1.13

1.5

1.4

6.57

6.51

mmol/l

0.04

218

severe traumatic brain injury, does not include concussion

110

915

1.20

1.12

1.3

1.4

6.57

6.33

mmol/l

0.41

102

833

Melanocytic naevi of upper limb, including shoulder

1.91

1.12

1.5

1.3

6.49

6.52

mmol/l

0.01

Benign neoplasm of brain and other parts of central nervous system

196

0.56

1.12

1.3

1.4

4.70

6.52

mmol/l

1.28

182

Benign leiomyoma with endometriosis

267

1.39

1.12

1.4

1.3

6.78

7.01

mmol/l

0.19

245

Lower back pain or/and sciatica

455

2884

1.09

1.11

1.4

1.3

6.47

6.27

mmol/l

0.72

418

2670

Dementia

188

1490

0.87

1.11

1.2

1.4

6.05

6.43

mmol/l

1.07

169

1384

Voice disturbances

102

844

1.21

1.11

1.4

6.03

6.42

mmol/l

0.68

777

Diabetic neuropathy

474

1.28

1.10

1.4

8.97

7.67

mmol/l

1.92

432

Exposure to other specified factors

284

2382

1.12

1.09

1.3

6.43

6.23

mmol/l

0.61

265

2194

Other symptoms and signs involving the nervous and musculoskeletal systems

159

1369

1.16

1.09

1.3

1.4

6.20

6.35

mmol/l

0.28

150

1253

Polyp of the female genital tract

544

0.80

1.09

1.5

1.3

6.16

6.50

mmol/l

0.55

514

Sensorineural hearing loss

378

2400

1.10

1.08

1.3

6.72

6.31

mmol/l

1.63

357

2211

Injuries to the shoulder and upper arm

370

2814

1.10

1.08

1.3

6.13

6.33

mmol/l

0.62

347

2594

Dental caries 3, only avohilmo

439

2047

1.10

1.08

1.4

1.3

6.20

6.33

mmol/l

0.45

396

1892

Dental caries 1 and operation codes, only avohilmo

537

0.81

1.08

1.4

1.3

6.04

6.19

mmol/l

0.22

503

Abnormalities of forces of labour

162

0.55

1.08

1.3

1.2

6.06

6.16

mmol/l

—

147

Coxibs

159

725

1.17

1.08

1.4

6.26

6.44

mmol/l

0.40

146

679

Outcome of delivery

152

0.61

1.08

1.0

1.1

5.76

6.24

mmol/l

0.33

136

Other congenital malformations of circulatory system

1.87

1.07

2.0

1.3

6.80

6.49

mmol/l

0.09

Nerve, nerve root and plexus disorders

490

2826

1.09

1.07

1.3

6.55

6.26

mmol/l

1.28

455

2609

Complications of labour and delivery

127

837

0.85

1.07

1.2

6.43

6.31

mmol/l

0.21

114

787

Papulosquamous disorders

158

1364

1.16

1.06

1.4

1.3

6.21

6.35

mmol/l

0.34

146

1257

Dental caries 3 and operation codes, only avohilmo

596

0.82

1.06

1.4

1.3

6.07

6.14

mmol/l

0.10

562

Acute alcohol intoxication, ICD10

622

1.24

1.06

1.2

1.4

6.10

6.29

mmol/l

0.23

575

Visual disturbances

190

1663

1.14

1.06

1.3

1.4

6.31

6.32

mmol/l

0.02

181

1528

Reactive arthropathies, FINNGEN

178

1.46

1.05

1.4

6.37

6.39

mmol/l

0.01

161

Focal epilepsy

695

1.22

1.05

1.3

1.4

6.14

6.39

mmol/l

0.46

640

Alzheimer’s disease, wide definition, excluding more controls

555

0.79

1.04

1.3

1.4

6.54

6.26

mmol/l

0.31

515

Other osteochondropathies

170

1.47

1.04

1.5

5.98

6.34

mmol/l

0.26

157

Gonarthrosis,primary

382

2636

0.91

1.03

1.4

1.3

6.23

6.38

mmol/l

0.56

357

2430

Urticaria

742

1.21

1.03

1.3

6.08

6.36

mmol/l

0.54

681

Other diseases of spinal cord

1.70

1.01

1.2

1.3

5.78

6.35

mmol/l

0.37

Diseases of salivary glands

572

1.24

1.01

1.3

6.70

6.35

mmol/l

0.37

534

Depression or dysthymia

328

1660

1.11

0.99

1.4

6.81

6.22

mmol/l

2.50

302

1552

Other disorders of lacrimal gland

127

1086

1.17

0.98

1.3

6.70

6.27

mmol/l

1.05

121

1005

Benign neoplasm: Other and unspecified parts of mouth

1.81

0.98

1.5

1.4

8.15

6.86

mmol/l

0.90

Malignant neoplasm of colon

602

1.23

0.98

1.3

1.4

6.56

6.40

mmol/l

0.15

555

Other neurotic disorders

140

1.51

0.97

1.4

1.3

6.73

6.61

mmol/l

0.05

130

Dorsopathies

475

2232

1.09

0.97

1.4

1.3

6.38

6.21

mmol/l

0.63

425

2065

Glaucoma

278

2199

1.11

0.97

1.3

6.56

6.33

mmol/l

0.50

262

2030

Symptoms and signs involving speech and voice

132

1135

1.16

0.96

1.4

1.3

6.05

6.38

mmol/l

0.67

122

1035

Dementia in other diseases classified elsewhere

186

0.59

0.96

1.0

1.4

5.19

6.47

mmol/l

0.83

174

Lesion of sciatic nerve

186

0.59

0.96

1.2

1.4

5.55

6.74

mmol/l

1.58

175

Postpartum care and examination

120

1.44

0.95

1.2

1.1

5.88

6.17

mmol/l

0.25

106

Demyelinating diseases of the central nervous system

174

1.44

0.95

1.1

1.3

5.45

6.31

mmol/l

0.93

159

Seborrhoeic keratosis

814

1.19

0.95

1.4

6.02

6.33

mmol/l

0.51

745

Neuromuscular dysfunction of bladder

311

1.32

0.95

1.3

1.4

6.28

6.46

mmol/l

0.17

289

Inguinal hernia, bilateral

470

1.26

0.95

1.6

1.4

6.61

6.25

mmol/l

0.30

426

Nonorganic sleeping disorders

462

1.26

0.93

1.2

1.4

5.99

6.31

mmol/l

0.45

434

Hydrocele

561

1.23

0.93

1.3

1.4

5.71

6.26

mmol/l

0.87

520

Wet age-related macular degeneration

756

1.20

0.93

1.4

6.55

6.36

mmol/l

0.25

696

Myocardial infarction, unclassifiable

138

1065

1.16

0.92

1.3

1.4

7.75

6.32

mmol/l

4.69

124

971

Oral lichen ruber planus, including avohilmo

146

0.55

0.92

1.6

1.3

5.22

6.44

mmol/l

—

133

Other joint disorders

382

1862

1.09

0.92

1.3

6.15

6.31

mmol/l

0.51

350

1715

Hypothyreosis and Thyroxine purchase for inclusion criteria

405

2456

1.09

0.92

1.3

6.36

6.32

mmol/l

0.14

381

2269

Degeneration of the brain due to alcohol

1.68

0.92

1.2

1.4

5.61

6.43

mmol/l

0.49

Postmenopausal bleeding

495

0.82

0.90

1.2

1.3

6.12

6.59

mmol/l

0.96

466

Prolonged pregnancy

153

1.43

0.89

1.4

1.2

4.90

6.00

mmol/l

1.88

137

Iridocyclitis

719

1.20

0.89

1.4

1.3

6.05

6.34

mmol/l

0.47

663

Organic, including symptomatic, mental disorders

267

1742

1.11

0.88

1.3

1.4

6.26

6.37

mmol/l

0.26

241

1618

Other bullous disorders

1.65

0.88

1.7

1.3

5.84

6.69

mmol/l

0.69

Noise effects on inner ear

156

0.57

0.88

1.2

1.5

6.69

6.37

mmol/l

—

147

Disorders of eyelid in diseases classified elsewhere

1.62

0.87

1.3

1.4

6.80

6.63

mmol/l

0.07

Chondropathies

405

1.26

0.86

1.4

5.67

6.26

mmol/l

0.98

380

Suppurative and unspecified otitis media

745

1.18

0.85

1.3

6.22

6.14

mmol/l

0.10

684

Inguinal or femoral hernia, bilateral

477

1.24

0.85

1.6

1.4

6.61

6.29

mmol/l

0.26

431

Additional codes for the location of defect, injury or illness

153

1.44

0.85

1.6

1.4

5.81

6.70

mmol/l

0.69

142

Anterior Iridocyclitis

631

1.21

0.85

1.4

6.03

6.31

mmol/l

0.40

586

Dissociative [conversion] disorders

1.76

0.83

1.6

1.1

5.57

6.72

mmol/l

—

Monoamine oxidase A inhibitors

371

1.27

0.83

1.3

1.4

6.22

6.31

mmol/l

0.05

344

Early lumbar disc prolapse, operated

154

1.43

0.83

1.2

1.3

5.92

6.03

mmol/l

0.05

144

Polycystic ovarian syndrome, consortium definition

205

1105

1.12

0.83

1.3

1.2

6.36

6.38

mmol/l

0.02

185

1037

Single delivery by caesarean section

173

0.70

0.82

1.1

1.2

6.08

6.01

mmol/l

0.06

152

Corneal ulcer

534

1.22

0.82

1.2

1.4

6.67

6.34

mmol/l

0.46

494

Other and unspecified follicular disorders

105

1.53

0.81

1.4

1.3

7.03

6.38

mmol/l

0.49

therapeutic use

1.58

0.81

1.3

7.14

6.84

mmol/l

0.14

Atopic dermatitis, strict definition with reimbursement

580

1.20

0.81

1.4

1.3

5.63

6.16

mmol/l

1.19

538

Tonsillectomy and adenotomy

112

903

0.86

0.81

1.2

1.3

5.83

6.09

mmol/l

0.56

104

827

Schizoaffective disorder

155

1.42

0.81

1.1

1.4

6.54

6.40

mmol/l

0.07

143

Hyperprolactinaemia

1.73

0.79

1.2

5.18

6.45

mmol/l

—

Dental pulpitis 4, only avohilmo

514

2506

1.07

0.78

1.3

6.26

6.30

mmol/l

0.11

476

2317

Glaucoma secondary to other eye disorders

131

1.46

0.78

1.4

6.39

6.67

mmol/l

0.22

125

Salpingitis and oophoritis

393

1.25

0.78

1.3

5.90

6.50

mmol/l

1.03

363

Injury of muscle and tendon at shoulder and upper arm level

125

1426

0.88

0.77

1.3

1.4

5.57

6.41

mmol/l

3.73

117

1303

Traumatic subdural haemorrhage

547

1.21

0.77

1.4

6.82

6.17

mmol/l

1.08

500

Focal epilepsy, mode (most common among epilepsy diagnosis)

603

1.20

0.76

1.3

1.4

5.93

6.35

mmol/l

0.89

558

Degeneration of nervous system due to alcohol

1.58

0.75

1.2

1.4

5.61

6.50

mmol/l

0.55

Other general symptoms and signs

1.52

0.75

1.3

6.21

6.69

mmol/l

0.36

Diseases of male genital organs

277

1279

1.10

0.75

1.4

6.34

6.10

mmol/l

0.68

252

1182

Labour and delivery complicated by umbilical cord complications

1.60

0.75

1.2

1.3

6.09

6.60

mmol/l

0.33

Any dementia, excluding more controls

162

1260

0.89

0.74

1.3

1.4

6.13

6.42

mmol/l

0.62

146

1168

Ulcerative colitis

744

1.17

0.73

1.4

6.57

6.31

mmol/l

0.37

689

Benign neoplasm: Liver/bile ducts

1.64

0.73

1.6

1.3

6.24

6.29

mmol/l

—

Agoraphobia

1.85

0.73

1.4

1.0

5.71

6.91

mmol/l

—

Use of ropinirole

135

0.59

0.73

1.4

5.64

6.54

mmol/l

—

126

HSIL lesion of the cervix uteri, vagina or vulva

298

1.28

0.73

1.3

1.2

6.10

6.09

mmol/l

0.01

278

Polymyalgia rheumatica

515

1.21

0.73

1.2

1.4

6.37

6.41

mmol/l

0.03

479

Transport accidents

167

1325

1.12

0.72

1.3

6.35

6.19

mmol/l

0.31

152

1213

Parkinson's disease

666

0.82

0.72

1.4

5.69

6.42

mmol/l

1.32

614

Single delivery by forceps and vacuum extractor

127

0.67

0.72

1.2

5.76

6.04

mmol/l

0.19

113

Hypothyroidism, strict autoimmune, 3 medication purchases required

357

2257

1.08

0.71

1.3

6.35

6.30

mmol/l

0.14

339

2084

HSIL lesion of the cervix uteri

246

1.30

0.71

1.2

6.01

6.14

mmol/l

0.09

226

Any dementia

175

1372

0.90

0.71

1.2

1.4

6.11

6.42

mmol/l

0.71

157

1275

Dislocation, sprain and strain of joints and ligaments of knee

166

1718

0.90

0.71

1.2

1.3

6.70

6.21

mmol/l

1.40

156

1584

Neovascular glaucoma

134

1.42

0.71

1.4

6.39

6.49

mmol/l

0.07

126

Spondylosis

245

1920

1.09

0.71

1.3

6.36

6.29

mmol/l

0.12

229

1774

Mental retardation, excluding more controls

1.58

0.71

1.6

1.3

5.61

6.74

mmol/l

—

Temporomandibular joint disorders

355

0.76

0.70

1.6

1.3

6.66

6.16

mmol/l

0.45

334

Colorectal adenocarcinoma

831

1.16

0.70

1.2

1.4

6.64

6.37

mmol/l

0.36

755

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

151

1380

0.89

0.70

1.3

6.18

6.27

mmol/l

0.17

139

1278

Parkinson's disease, including avohilmo

695

0.83

0.69

1.4

5.78

6.37

mmol/l

1.03

639

Fitting and adjustment of other devices

143

1185

1.12

0.69

1.3

6.76

6.29

mmol/l

0.88

132

1078

Acetic acid derivatives and related substances

156

725

1.12

0.68

1.4

6.16

6.44

mmol/l

0.40

140

679

Bipolar affective disorders

419

1.22

0.68

1.1

1.3

5.82

6.20

mmol/l

0.39

388

Injury of muscle and tendon at wrist and hand level

419

0.79

0.67

1.3

1.4

6.50

6.30

mmol/l

0.21

386

Other/unspecified reactive arthropathies

170

1.36

0.67

1.4

1.3

6.47

6.60

mmol/l

0.11

158

Focal epilepsy, strict definition

650

1.17

0.66

1.3

1.4

6.27

6.39

mmol/l

0.16

600

Other disorders of eyelid

207

1823

1.10

0.66

1.3

1.4

6.48

6.35

mmol/l

0.27

192

1679

Crystal arthropathies, rheuma endpoint

1.58

0.65

1.6

1.5

5.87

7.45

mmol/l

0.97

Diabetes mellitus in pregnancy

295

1.21

0.65

1.2

7.04

5.94

mmol/l

1.82

270

Certain conditions originating in the perinatal period

1.54

0.65

1.4

1.2

5.78

6.10

mmol/l

0.15

Arthrosis

341

1742

1.08

0.65

1.4

1.3

6.19

6.38

mmol/l

0.58

308

1605

Papillary adenocarcinoma of thyroid gland

120

1.42

0.64

1.4

1.3

5.82

6.58

mmol/l

0.75

110

Bicipital tendinitis

131

0.61

0.63

1.4

4.67

6.35

mmol/l

—

120

Colonic or urogenital fistula

104

915

1.14

0.63

1.3

1.4

6.15

6.34

mmol/l

0.36

840

Appendectomy

225

1991

1.09

0.62

1.3

6.02

6.28

mmol/l

0.74

204

1842

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

252

1.27

0.61

1.3

1.4

6.38

6.44

mmol/l

0.04

235

Carpal tunnel syndrome

208

2047

0.92

0.61

1.3

6.78

6.33

mmol/l

1.24

194

1884

Blepharochalasis

124

1107

1.12

0.60

1.2

1.3

6.45

6.34

mmol/l

0.17

114

1014

Crohn's disease of large intestine

105

1.43

0.60

1.5

1.2

5.93

6.57

mmol/l

0.48

Other intervertebral disc disorders

378

2168

1.07

0.60

1.4

1.3

6.42

6.25

mmol/l

0.57

350

2005

Diseases of middle ear and mastoid

187

1399

1.10

0.58

1.3

6.33

6.22

mmol/l

0.22

175

1274

Dermatitis herpetiformis

1.52

0.58

1.5

1.2

5.39

6.69

mmol/l

—

Leiomyoma of uterus

191

991

1.10

0.58

1.2

1.3

6.50

6.45

mmol/l

0.11

175

928

Cervicocranial syndrome

287

0.77

0.57

1.5

1.4

6.03

6.34

mmol/l

0.51

271

Major anomalies of jaw size

1.49

0.57

1.0

1.2

5.64

6.67

mmol/l

—

Dental pulpitis 1, only avohilmo

509

2518

1.06

0.56

1.3

6.23

6.31

mmol/l

0.26

471

2329

Alzheimer’s disease (Late onset), excluding more controls

518

0.86

0.56

1.3

1.4

6.36

6.22

mmol/l

0.15

486

Chronic rhinitis, nasopharyngitis and pharyngitis

108

963

1.12

0.55

1.5

1.3

5.70

6.31

mmol/l

1.85

100

889

Mood [affective] disorders

375

2619

0.94

0.54

1.3

6.45

6.28

mmol/l

0.51

340

2420

Other abnormal uterine and vaginal bleeding

485

1.15

0.54

1.3

6.88

6.52

mmol/l

0.54

456

Contact with other sharp object(s)

125

0.64

0.54

1.4

1.3

4.97

6.33

mmol/l

—

114

Acute and subacute iridocyclitis

598

1.16

0.54

1.4

6.14

6.30

mmol/l

0.19

554

Benign neoplasm: Larynx

1.50

0.54

1.2

1.4

6.60

6.76

mmol/l

—

Benign neoplasm: Long bones of lower limb

1.50

0.54

1.2

5.69

6.25

mmol/l

—

Other enthesopathies

106

946

1.12

0.54

1.5

1.3

6.05

6.23

mmol/l

0.31

874

Mood disorders

377

2628

0.94

0.54

1.3

6.45

6.28

mmol/l

0.50

342

2429

Dental caries 2

220

1866

0.93

0.53

1.3

6.08

6.26

mmol/l

0.48

207

1720

Coxarthrosis, primary, with hip surgery

199

2041

0.92

0.52

1.4

1.3

6.42

6.35

mmol/l

0.15

188

1884

Mental retardation

1.41

0.51

1.6

1.2

5.61

6.56

mmol/l

—

Disorders of synovium and tendon

174

1702

0.92

0.50

1.5

1.3

6.39

6.32

mmol/l

0.12

165

1567

Stenosis and insufficiency of lacrimal passages

288

1.22

0.50

1.3

1.4

6.67

6.40

mmol/l

0.17

270

Vasomotor rhinitis (mode)

213

0.75

0.50

1.3

1.4

6.91

6.48

mmol/l

0.17

197

Mouth breathing

155

1419

1.09

0.49

1.3

6.45

6.30

mmol/l

0.22

141

1298

Artificial joint re-operation

234

1.24

0.49

1.4

6.82

6.64

mmol/l

0.11

219

Pain in joint

236

1454

1.07

0.49

1.4

1.3

6.29

6.15

mmol/l

0.29

218

1337

Malignant melanoma

576

1.15

0.49

1.4

6.41

6.35

mmol/l

0.05

535

Other/unspecified enthesopathies of lower limb, excluding foot

163

1.29

0.48

1.7

1.4

6.01

6.38

mmol/l

0.33

155

Personal history of malignant neoplasm

1.45

0.48

1.4

1.2

6.19

6.57

mmol/l

0.11

Pedal cyclist injured in transport accident

625

0.86

0.48

1.4

5.75

6.33

mmol/l

0.92

579

Unspecified dementia

515

0.86

0.47

1.3

1.4

5.76

6.55

mmol/l

1.27

472

Rotator cuff syndrome

278

1939

1.07

0.46

1.3

6.20

6.29

mmol/l

0.20

251

1789

Otitis externa

654

1.13

0.46

1.3

1.4

6.56

6.29

mmol/l

0.32

607

Contact with heat and hot substances

129

1.32

0.45

1.2

1.3

7.52

6.48

mmol/l

1.31

122

Contact with nonpowered hand tool

121

0.66

0.45

1.5

5.94

6.39

mmol/l

—

113

Single spontaneous delivery

102

602

0.90

0.44

1.4

1.3

6.53

6.54

mmol/l

0.02

556

Other specified/unspecified inflammatory spondylopathies

1.40

0.44

1.2

1.4

6.57

6.44

mmol/l

0.06

Carcinoma in situ, bladder

139

1.30

0.44

1.6

1.5

7.31

6.62

mmol/l

0.59

131

Impingement syndrome of shoulder

883

0.89

0.43

1.3

6.60

6.23

mmol/l

0.47

816

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

200

1.23

0.43

1.1

1.3

5.70

5.74

mmol/l

0.02

188

Dystonia

140

0.71

0.43

1.4

1.3

5.97

6.57

mmol/l

—

129

Early lumbar disc prolapse operation

175

1.26

0.43

1.2

1.3

5.92

6.17

mmol/l

0.12

160

Nontoxic single thyroid nodule

196

0.76

0.42

1.5

6.24

6.55

mmol/l

0.18

187

Injury of muscle and tendon at ankle and foot level

1.43

0.42

1.6

1.4

5.64

6.80

mmol/l

—

Anankastic personality disorder

1.43

0.42

1.5

1.2

5.58

6.42

mmol/l

—

Cramp and spasm

122

1.31

0.42

1.6

1.4

5.90

6.59

mmol/l

0.47

112

Benign neoplasm of other and unspecified female genital organs

0.64

0.42

1.0

1.2

5.48

6.61

mmol/l

—

Erythema intertrigo

1.43

0.42

1.3

1.2

6.57

6.52

mmol/l

—

MS-disease / Multiple Sclerosis

140

1.29

0.42

1.2

1.4

5.29

6.40

mmol/l

1.10

126

Benign neoplasm: Skin of scalp and neck

1.43

0.42

1.3

1.4

5.50

6.89

mmol/l

—

Dental caries 2 and operation codes

216

1828

0.94

0.40

1.3

6.07

6.27

mmol/l

0.52

204

1682

Other inflammation of eyelid

389

1.16

0.40

1.4

6.18

6.32

mmol/l

0.14

364

Injury of muscle and tendon at hip and thigh level

271

0.81

0.40

1.7

1.5

6.17

6.27

mmol/l

0.05

248

Atlantoaxial subluxation

0.00

0.40

0.0

1.3

—

6.98

—

Spermatocele

336

0.83

0.40

1.2

1.4

6.37

6.28

mmol/l

0.07

312

Ménière disease

325

0.83

0.40

1.3

1.4

6.27

6.44

mmol/l

0.17

303

Chalazion

325

0.83

0.40

1.6

1.4

6.09

6.18

mmol/l

0.07

304

Myasthenia gravis

1.32

0.39

1.4

1.3

5.59

6.26

mmol/l

—

Striking against or struck by other objects

104

949

1.10

0.39

1.2

1.4

6.21

6.23

mmol/l

0.02

869

Campylobacter enteritis

1.41

0.39

1.3

1.4

6.07

6.82

mmol/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

462

1.14

0.39

1.2

6.22

6.21

mmol/l

0.01

432

Delivery

104

603

0.91

0.38

1.4

1.3

6.52

6.54

mmol/l

0.02

556

Gonarthrosis [arthrosis of knee](FG)

348

1950

1.05

0.38

1.4

1.3

6.29

6.36

mmol/l

0.19

323

1793

Sciatica+with lumbago

195

1737

1.07

0.38

1.4

1.3

6.32

6.31

mmol/l

0.01

181

1606

Pregnancy with abortive outcome

169

948

0.93

0.37

1.3

6.27

6.43

mmol/l

0.34

157

888

Other disorders of amniotic fluid and membranes

150

1.26

0.37

1.1

1.3

5.73

5.92

mmol/l

0.22

131

Urolithiasis

130

1404

0.93

0.37

1.5

1.4

6.20

6.27

mmol/l

0.11

121

1293

Inflammatory disorders of breast

1.33

0.37

1.2

1.3

6.43

6.41

mmol/l

0.01

Glucosamine medication

211

1788

0.94

0.37

1.4

6.51

6.41

mmol/l

0.21

191

1656

Other and unspecified epidermal thickening

1.31

0.37

1.4

6.74

6.81

mmol/l

—

Mental retardation, wide definition

1.39

0.36

1.5

1.2

5.55

6.47

mmol/l

—

Menorrhagia

559

0.91

0.36

1.3

6.89

6.47

mmol/l

0.79

529

Fall on same level involving ice and snow

212

1999

1.06

0.36

1.3

6.44

6.32

mmol/l

0.22

200

1841

Unspecified urinary incontinence

245

0.82

0.36

1.3

1.4

7.50

6.38

mmol/l

1.01

232

Follow-up care involving plastic surgery

0.64

0.35

1.2

4.72

6.71

mmol/l

—

Redundant prepuce, phimosis and paraphimosis

713

1.10

0.35

1.5

1.4

6.90

6.18

mmol/l

1.09

657

Crohn disease (strict definition, all UC cases excluded)

1.32

0.35

1.4

1.3

5.79

6.61

mmol/l

0.51

Sequelae of other and unspecified infectious and parasitic diseases

117

1.28

0.35

1.1

1.3

5.46

6.45

mmol/l

—

109

Benign neoplasm: Skin of lower limb, including hip

1.40

0.35

2.2

1.3

5.53

7.13

mmol/l

—

Trochanteric bursitis

394

0.86

0.34

1.4

1.3

6.58

6.43

mmol/l

0.12

363

Peripheral retinal degeneration

1.34

0.34

1.5

1.4

6.51

6.40

mmol/l

0.09

Parkinson's disease, excluding more controls

600

0.89

0.34

1.4

5.69

6.23

mmol/l

0.84

550

Irregular menses

104

777

1.09

0.33

1.4

1.2

5.82

6.23

mmol/l

0.89

728

Other disorders of the musculoskeletal system and connective tissue

472

1.12

0.33

1.2

1.4

6.47

6.42

mmol/l

0.05

440

Subarachnoid haemorrhage

359

1.14

0.33

1.7

1.4

6.11

6.22

mmol/l

0.12

335

Undefined dementia

506

0.89

0.32

1.3

1.4

5.76

6.60

mmol/l

1.38

461

Gestational diabetes (for exclusion)

361

1.12

0.32

1.2

6.62

5.92

mmol/l

1.15

333

Generalized skin eruption due to drugs and medicaments

101

1.29

0.31

1.7

1.3

6.59

6.71

mmol/l

0.04

Artificial joint operation, meniscal resection

393

2717

0.96

0.31

1.3

6.19

6.35

mmol/l

0.62

371

2507

Atrophic disorders of skin

342

1.14

0.31

1.6

1.3

6.24

6.50

mmol/l

0.32

318

Benign neoplasm: Liver

1.35

0.31

1.7

1.3

5.91

6.39

mmol/l

—

Disorders of vitreous body

179

1853

0.94

0.31

1.3

1.4

6.98

6.31

mmol/l

1.82

170

1712

Foreign body entering into or through eye or natural orifice

221

1.18

0.30

1.7

1.4

6.01

6.45

mmol/l

0.34

203

Benign neoplasm: Skin of ear and external auricular canal

1.31

0.30

1.3

6.68

7.53

mmol/l

0.45

Benign neoplasm: Pituitary gland, craniopharyngeal duct

1.31

0.30

1.2

1.3

6.75

6.60

mmol/l

0.08

Acne vulgaris

1.31

0.30

1.2

5.16

5.85

mmol/l

0.96

Triptan medication for migraine, min. 3 purchases

114

965

0.93

0.29

1.2

1.3

5.70

6.24

mmol/l

1.58

102

900

Benign neoplasm: Choroid

194

1.19

0.29

1.2

1.4

6.79

6.60

mmol/l

0.14

182

Primary coxarthrosis, bilateral

117

1252

0.93

0.29

1.3

1.4

6.85

6.41

mmol/l

0.95

109

1141

Benign neoplasm: Skin of ear and external auricular canal

141

0.78

0.29

1.3

1.4

6.68

6.53

mmol/l

0.08

136

Recurrent or chronic depression

119

802

1.07

0.29

1.3

6.48

6.20

mmol/l

0.44

107

747

Extrapyramidal and movement disorders

141

1498

0.94

0.29

1.3

1.4

5.90

6.34

mmol/l

1.21

130

1371

Atopic dermatitis

134

1215

0.94

0.28

1.3

5.98

6.23

mmol/l

0.58

128

1117

Carcinoma in situ of other and unspecified sites

149

1.21

0.28

1.6

1.5

7.31

6.54

mmol/l

0.70

140

Disorders of vestibular function (Vertigo)

171

1790

0.95

0.27

1.3

1.4

6.69

6.39

mmol/l

0.67

159

1651

Other demyelinating diseases of the central nervous system

1.25

0.27

1.1

4.93

6.49

mmol/l

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

1.23

0.27

1.1

1.3

6.56

6.37

mmol/l

—

Pain associated with micturition

337

1.13

0.27

1.4

5.94

6.50

mmol/l

0.89

316

Other disorders of bladder

499

1.10

0.27

1.5

1.4

5.77

6.37

mmol/l

1.60

455

Allergic purpura

1.23

0.27

1.4

1.2

6.99

6.59

mmol/l

—

Nasal polyp

761

0.92

0.27

1.3

1.4

6.03

6.38

mmol/l

0.45

704

Alzheimer’s disease (Atypical or mixed)

415

0.89

0.27

1.4

6.50

6.60

mmol/l

0.08

381

Nonspecific lymphadenitis

128

0.78

0.26

1.8

1.4

5.56

6.37

mmol/l

—

116

Selective serotonin reuptake inhibitors

458

2335

1.03

0.26

1.3

6.43

6.23

mmol/l

0.62

419

2172

Contact with sharp glass

1.20

0.26

1.4

1.3

6.15

6.43

mmol/l

—

Maternal care for cervical incompetence

0.70

0.26

1.0

1.2

6.62

6.67

mmol/l

—

Acute nasopharyngitis (common cold)

261

1.14

0.26

1.4

1.3

6.50

6.45

mmol/l

0.04

235

Pilonidal cyst

169

1.18

0.25

1.3

4.74

6.08

mmol/l

1.93

153

Infections of genitourinary tract in pregnancy

149

0.80

0.25

1.3

5.64

6.12

mmol/l

0.46

140

Disorders of vitreous body and globe

188

1922

0.95

0.25

1.3

1.4

6.90

6.31

mmol/l

1.58

179

1778

Carcinoma in situ of skin of trunk

123

1.22

0.25

1.3

1.5

5.83

6.79

mmol/l

0.66

118

Vasomotor and allergic rhinitis

1012

0.93

0.25

1.3

6.65

6.26

mmol/l

0.56

930

Bell's palsy

368

1.12

0.25

1.2

1.4

6.20

6.46

mmol/l

0.27

340

Maternal care for known or suspected fetal abnormality and damage

159

1.18

0.25

1.1

1.2

5.80

6.21

mmol/l

0.40

140

Cystitis

339

2145

0.97

0.24

1.4

1.3

6.47

6.29

mmol/l

0.53

313

1987

Ovarian cyst

105

569

1.07

0.24

1.3

6.13

6.44

mmol/l

0.61

537

Oral leukoplakia, including avohilmo

0.73

0.24

1.2

1.3

8.35

6.80

mmol/l

—

Benign neoplasm: Cranial nerves

0.71

0.24

1.3

1.4

4.50

6.55

mmol/l

—

Meniscus derangement

231

1647

0.96

0.24

1.3

6.26

6.40

mmol/l

0.36

213

1519

Hypertrophy of breast

318

0.88

0.24

1.1

1.3

6.05

6.24

mmol/l

0.29

295

Primary open-angle glaucoma, strict

119

1121

1.06

0.24

1.4

6.61

6.42

mmol/l

0.20

114

1024

Seborrhoeic dermatitis

322

1.12

0.23

1.3

1.4

5.96

6.40

mmol/l

0.80

299

Preterm labour and delivery

495

0.91

0.23

1.0

1.2

6.41

6.25

mmol/l

0.16

463

Postpartum haemorrhage due to anatomy

106

1.23

0.23

1.2

1.3

6.33

6.22

mmol/l

0.08

100

Tongue abnormality

179

0.84

0.23

1.5

1.3

5.65

6.60

mmol/l

0.83

167

Plantar fascial fibromatosis

256

1.13

0.23

1.2

1.4

5.83

6.28

mmol/l

0.61

239

Endometriosis

100

558

1.07

0.23

1.3

6.18

6.44

mmol/l

0.48

528

Gonarthrosis

305

1689

1.04

0.23

1.4

1.3

6.25

6.39

mmol/l

0.36

283

1556

Crowding of teeth, including avohilmo

0.75

0.22

1.3

1.2

4.99

6.21

mmol/l

—

Otitis media, unspecified

184

0.85

0.22

1.2

1.3

6.89

6.37

mmol/l

0.33

169

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

154

1444

1.05

0.22

1.3

6.06

6.31

mmol/l

0.63

139

1340

Other arthrosis

231

1590

1.04

0.21

1.4

1.3

6.05

6.39

mmol/l

1.07

210

1463

Migraine

108

972

0.94

0.21

1.2

1.3

6.14

6.23

mmol/l

0.19

101

910

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

0.00

0.21

0.0

1.5

—

6.56

—

Oesophagitis, drug-induced

0.00

0.21

0.0

1.5

—

6.73

—

Vaginal lichen planus

0.00

0.21

0.0

1.1

—

6.85

—

Gender identity disorders

0.00

0.21

0.0

1.0

—

6.30

—

Disorders of puberty

0.00

0.21

0.0

1.1

—

6.55

—

Sequelae of inflammatory diseases of the central nervous system

0.00

0.21

0.0

1.2

—

6.43

—

Female infertility

388

0.92

0.21

1.1

1.3

6.12

mmol/l

0.00

374

Disorders of puberty, all

0.00

0.21

0.0

1.1

—

6.47

—

Other complications of labour and delivery, not elsewhere classified

101

0.76

0.21

1.1

1.2

5.75

5.73

mmol/l

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

130

685

1.05

0.21

1.5

1.4

6.31

6.48

mmol/l

0.28

120

643

Typhoid and paratyphoid fevers

0.00

0.20

0.0

1.5

—

6.91

—

Artrosis, including avohilmo

379

2138

0.97

0.20

1.3

6.19

6.37

mmol/l

0.60

340

1976

Pregnancy, childbirth and the puerperium

468

0.94

0.20

1.3

1.2

6.93

6.57

mmol/l

0.43

432

Hereditary corneal dystrophies

1.22

0.19

1.2

1.4

6.85

6.65

mmol/l

0.11

Benign neoplasm: Cranial nerves

1.15

0.19

1.3

4.50

7.24

mmol/l

—

Algoneurodystrophy

1.15

0.19

1.0

1.3

6.33

6.76

mmol/l

—

All dysplastic lesions of the cervix uteri

384

1.09

0.19

1.2

6.14

6.12

mmol/l

0.01

357

Correction of physiology of bite - very demanding therapy visit

1.13

0.18

1.7

1.2

5.22

6.85

mmol/l

—

Haemorrhoids and perianal venous thrombosis

111

1165

0.95

0.18

1.3

1.4

6.31

6.35

mmol/l

0.06

103

1071

Dysplasia of cervi uteri

365

1.08

0.18

1.2

1.3

6.25

6.24

mmol/l

0.01

348

Acute appendicitis, no complications

170

1762

0.96

0.18

1.3

6.12

6.20

mmol/l

0.14

157

1624

Dermatitis due to substances taken internally

147

1.16

0.18

1.5

1.3

7.04

6.66

mmol/l

0.17

137

Autonomic disorders

1.19

0.18

1.0

1.3

6.36

6.49

mmol/l

—

Allergic contact dermatitis due to drugs in contact with skin

1.19

0.18

1.6

1.2

6.77

6.71

mmol/l

—

Excessive attrition of teeth

115

655

0.95

0.18

1.3

6.05

6.16

mmol/l

0.19

106

611

Injury of nerves at wrist and hand level

1.21

0.17

1.1

1.3

6.27

6.24

mmol/l

0.01

Acne

119

1.18

0.17

1.1

1.2

5.27

6.05

mmol/l

1.22

112

Intermittent heterotropia

1.21

0.17

1.8

1.3

6.65

6.43

mmol/l

0.11

Brain meningioma

142

0.84

0.17

1.3

7.33

6.61

mmol/l

0.28

133

Diseases of external ear

123

1177

1.05

0.17

1.3

1.4

6.23

6.36

mmol/l

0.19

112

1075

Excessive, frequent and irregular menstruation

100

585

0.95

0.17

1.3

6.27

6.40

mmol/l

0.19

553

Family history of certain disabilities and chronic diseases leading to disablement

1.11

0.17

1.3

1.2

5.43

6.50

mmol/l

—

Other and unspecified mononeuropathies of lower limb

0.75

0.17

1.4

1.3

6.12

7.15

mmol/l

—

Acute appendicitis

255

2336

1.03

0.17

1.3

6.33

6.25

mmol/l

0.16

234

2154

Benign neoplasm of bone and articular cartilage

205

1.12

0.17

1.4

4.82

6.44

mmol/l

1.60

191

Traumatic amputation of wrist and hand

152

0.85

0.17

1.4

1.5

7.05

6.39

mmol/l

0.39

141

Inflammatory disease of cervix uteri

152

0.85

0.17

1.6

1.3

6.19

6.57

mmol/l

0.21

144

Cervical disc disorders

133

1385

0.96

0.16

1.3

6.26

6.29

mmol/l

0.05

125

1280

Other diseases of hard tissues of teeth

226

1737

0.97

0.16

1.4

1.3

6.11

6.31

mmol/l

0.50

212

1612

Female infertility, cervigal, vaginal, other or unspecified origin

380

0.93

0.16

1.1

1.3

6.18

6.16

mmol/l

0.01

366

Secondary polycythaemia

1.14

0.16

1.1

1.4

7.71

6.34

mmol/l

—

Embedded teeth, including avohilmo

120

1.17

0.16

1.2

5.55

6.14

mmol/l

0.41

112

Cyst of Bartholin Gland

1.13

0.16

1.4

1.2

5.76

6.70

mmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

1.20

0.16

1.5

1.3

5.67

6.28

mmol/l

0.78

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

1.20

0.16

1.5

1.3

5.67

6.45

mmol/l

1.08

Benign neoplasm: Pituitary gland, craniopharyngeal duct

130

0.85

0.16

1.2

1.3

6.75

6.55

mmol/l

0.12

120

Benign neoplasm of brain and other parts of central nervous system

130

0.85

0.16

1.3

1.4

4.70

7.05

mmol/l

1.71

117

Other disorders of Eustachian tube

1.10

0.15

1.4

1.3

6.50

6.68

mmol/l

—

Benign neoplasm: Skin of lower limb, including hip

0.78

0.15

2.2

1.3

5.53

6.89

mmol/l

—

Amblyopia ex anopsia

0.78

0.15

1.3

7.48

6.66

mmol/l

—

Car occupant injured in noncollision transport accident

1.14

0.15

1.3

6.14

6.50

mmol/l

—

Glaucoma suspect

146

1409

1.04

0.15

1.3

6.71

6.38

mmol/l

0.67

138

1289

Testicular dysfunction

1.10

0.15

1.2

1.5

9.06

6.27

mmol/l

—

Other specified/unspecified bacterial intestinal infections

188

1.12

0.14

1.6

1.3

7.20

6.56

mmol/l

0.57

175

Use of rasagiline

0.81

0.14

1.3

1.5

4.93

6.38

mmol/l

—

Other puerperal infections

1.08

0.14

1.1

1.2

4.79

6.22

mmol/l

—

Pneumoconiosis due to asbestos and other mineral fibres

112

1.16

0.14

1.2

1.5

7.22

6.53

mmol/l

0.32

106

Other specified and unspecified retinal disorders

112

1.16

0.14

1.6

1.5

5.51

6.56

mmol/l

1.23

105

malignant neoplasm of male genital organs

243

1502

1.03

0.14

1.4

6.09

6.29

mmol/l

0.46

213

1391

Allergic conjunctivitis

159

1514

1.03

0.14

1.3

6.06

6.31

mmol/l

0.65

144

1406

Open wound of wrist and hand

138

1415

0.97

0.14

1.3

5.96

6.25

mmol/l

0.59

133

1288

Follow-up examination after treatment for conditions other than malignant neoplasms

172

1091

1.03

0.14

1.3

6.42

6.12

mmol/l

0.72

164

1007

Oral lichen ruber planus wide, hypothyreosis or thyroxin

139

0.86

0.14

1.4

1.3

5.88

6.51

mmol/l

0.47

131

Other diseases of gallbladder

141

1.14

0.14

1.6

1.3

6.31

6.62

mmol/l

0.21

135

Adenomyosis (Endometriosis of uterus)

363

1.07

0.13

1.5

1.3

6.07

6.55

mmol/l

0.47

344

Propionic acid derivatives

140

729

0.96

0.13

1.4

6.43

mmol/l

0.01

134

683

Lumbar disc prolapse

256

1986

1.02

0.13

1.4

1.3

6.52

6.26

mmol/l

0.69

238

1839

Monoarthritis, not elsewhere classified

113

1.15

0.13

1.4

1.3

6.02

6.71

mmol/l

0.39

105

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

108

0.83

0.13

1.6

1.2

5.76

6.18

mmol/l

—

Benign neoplasm: Larynx

110

0.82

0.13

1.2

1.4

6.60

6.41

mmol/l

—

104

Other benign neoplasms of skin

146

1415

1.03

0.12

1.3

6.23

6.38

mmol/l

0.34

137

1293

Abnormal findings in secretions and smears from cervix uteri vagina vulva

752

0.96

0.12

1.2

1.3

5.99

6.30

mmol/l

0.66

703

Persons encountering health services in circumstances related to reproduction

147

1027

0.97

0.12

1.3

6.03

6.26

mmol/l

0.59

140

933

Inflammatory diseases of prostate (prostatitis)

581

1.05

0.11

1.6

1.4

6.54

6.22

mmol/l

0.59

539

Injuries to the wrist and hand

377

2779

0.98

0.11

1.4

1.3

6.25

6.28

mmol/l

0.05

355

2560

Vascular syndromes of brain in cerebrovascular disorders

201

1.10

0.11

1.3

1.4

6.14

6.66

mmol/l

0.43

190

Effects of foreign body entering through natural orifice

782

0.96

0.11

1.3

1.4

5.80

6.31

mmol/l

0.98

721

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

816

1.04

0.11

1.4

1.3

6.19

mmol/l

0.00

755

Conjunctivitis

240

2046

1.02

0.11

1.3

6.07

6.35

mmol/l

0.89

219

1888

Depression

346

2423

0.98

0.10

1.3

6.44

6.27

mmol/l

0.47

312

2235

Excessive vomiting in pregnancy

115

1.13

0.10

1.3

5.76

6.24

mmol/l

0.34

107

Other noninflammatory disorders of cervix uteri

125

0.88

0.10

1.2

1.3

6.73

6.60

mmol/l

0.05

118

Deforming dorsopathies

889

1.04

0.10

1.4

1.3

6.38

6.34

mmol/l

0.04

831

Crushed, pushed or stepped on by crowd or human stampede

125

1.12

0.10

1.4

1.3

5.53

6.48

mmol/l

0.95

118

Coxarthrosis, primary

279

2378

1.02

0.10

1.4

6.53

6.36

mmol/l

0.51

265

2194

Diseases of tongue

197

0.91

0.10

1.5

5.70

6.53

mmol/l

0.87

186

Special screening examination for infectious and parasitic diseases

407

0.95

0.09

1.2

1.3

5.46

5.99

mmol/l

0.79

375

Primary open-angle glaucoma

146

1388

1.03

0.09

1.4

6.47

6.39

mmol/l

0.08

138

1272

Localized swelling, mass and lump of skin and subcutaneous tissue

104

1070

0.97

0.09

1.3

1.4

6.23

6.35

mmol/l

0.24

976

Benign neoplasm of other and unspecified female genital organs

1.09

0.09

1.0

1.2

5.48

7.07

mmol/l

—

Hypertrophy of breast in women and men

439

1.05

0.08

1.2

1.4

6.53

6.29

mmol/l

0.35

409

Benign neoplasm of male genital organs

1.05

0.08

1.0

1.3

7.08

7.27

mmol/l

—

Burn and corrosion of head and neck

1.05

0.08

1.0

1.2

5.75

6.41

mmol/l

—

Struck by thrown, projected or falling objec

113

0.88

0.08

1.6

1.4

6.88

6.64

mmol/l

—

103

LeFortI or BSSRO operation

0.83

0.08

1.0

1.2

4.54

6.23

mmol/l

—

Mumps

0.81

0.08

1.6

1.3

5.92

6.25

mmol/l

—

Contact with other hot fluids

0.81

0.08

1.2

7.90

6.28

mmol/l

—

Urethritis and urethral syndrome

0.79

0.08

1.2

1.3

6.46

6.86

mmol/l

—

conjunctival degenerations and deposits

0.77

0.08

1.2

1.3

6.40

7.01

mmol/l

—

Other sexually transmitted chlamydial diseases

0.77

0.08

1.2

1.1

2.48

6.32

mmol/l

—

Calculus of kidney and ureter

124

1270

0.98

0.08

1.5

1.4

6.21

6.32

mmol/l

0.17

117

1164

Panniculitis affecting regions of neck and back

1.14

0.08

1.3

1.4

6.05

6.60

mmol/l

—

Dislocation, sprain and strain of joints and ligaments of head

1.06

0.08

1.7

1.2

7.33

6.73

mmol/l

—

Burn and corrosion of trunk

1.04

0.07

1.1

1.3

6.00

6.64

mmol/l

—

Other disorders of iris and ciliary body

1.03

0.07

1.9

1.4

7.60

6.51

mmol/l

—

Congenital iodine-deficiency syndrome/hypothyroidism

1.03

0.07

1.5

1.2

6.38

7.06

mmol/l

—

Optic neuritis

1.03

0.07

1.1

1.2

7.35

6.52

mmol/l

—

Meralgia paraesthetica

0.85

0.07

1.4

1.3

4.74

6.85

mmol/l

—

Hyperkinetic disorders, excluding more controls

1.04

0.07

1.0

1.2

5.66

5.89

mmol/l

—

Anti-inflammatory and antirheumatic products, non-steroids

148

729

1.02

0.07

1.4

6.22

6.43

mmol/l

0.44

139

683

Abnormal findings on diagnostic imaging of central nervous system

1.03

0.07

1.3

6.48

6.74

mmol/l

—

Scabies

1.12

0.06

1.1

1.3

6.74

6.21

mmol/l

—

Benign mammary dysplasia

336

0.95

0.06

1.3

7.14

6.55

mmol/l

0.41

312

Other intracranial haemorrhages

132

0.91

0.06

1.4

7.08

6.30

mmol/l

0.47

124

Benign neoplasm: Other and unspecified parts of mouth

1.11

0.06

1.5

1.3

8.15

6.66

mmol/l

1.23

Endometriosis of pelvic peritoneum

311

0.95

0.06

1.1

1.3

5.91

6.27

mmol/l

0.37

299

Presence of other devices

941

0.98

0.06

1.3

1.4

7.15

6.17

mmol/l

2.86

861

Medical abortion

175

936

1.02

0.06

1.4

1.3

6.26

6.44

mmol/l

0.46

164

877

Pediculosis, acariasis and other infestations

129

1.09

0.05

1.2

1.3

6.59

6.41

mmol/l

0.11

118

Alzheimer’s disease (Atypical or mixed), excluding more controls

324

0.96

0.05

1.3

1.4

6.51

6.36

mmol/l

0.12

305

Macular hole

198

1.06

0.05

1.3

1.4

6.00

6.56

mmol/l

0.40

185

Other disorders of nervous system

202

0.94

0.05

1.9

1.5

6.45

6.50

mmol/l

0.03

187

Allergic rhinitis

640

0.97

0.05

1.3

1.4

6.65

6.11

mmol/l

0.69

592

Spontaneous abortion

686

0.98

0.04

1.2

6.61

6.32

mmol/l

0.50

643

Benign paroxysmal vertigo

100

1018

0.98

0.04

1.4

1.3

6.66

6.39

mmol/l

0.39

934

Other headache syndromes

127

1251

1.02

0.04

1.3

6.53

6.25

mmol/l

0.56

117

1165

Benign neoplasm: Skin of eyelid, including canthus

516

1.03

0.04

1.3

1.4

6.70

6.38

mmol/l

0.39

480

Deviated nasal septum

132

1301

1.01

0.04

1.3

5.81

6.40

mmol/l

1.60

117

1199

Carcinoma in situ of breast, intraductal

190

0.95

0.04

1.2

1.3

6.54

6.58

mmol/l

0.01

176

Laparoscopic right hemicolectomy

200

1.05

0.03

1.1

1.4

7.33

6.61

mmol/l

0.36

190

Appendicitis, broad definition

271

2457

1.01

0.03

1.3

6.33

6.23

mmol/l

0.22

247

2263

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

131

1.07

0.03

1.5

1.3

5.78

6.41

mmol/l

0.73

120

Disorders of breast

123

1125

1.01

0.03

1.2

1.3

6.46

6.43

mmol/l

0.04

113

1053

Other diseases of upper respiratory tract

503

2637

0.99

0.03

1.4

1.3

6.19

6.35

mmol/l

0.58

464

2438

Sequelae of infectious and parasitic diseases

230

1.04

0.03

1.1

1.3

5.93

6.56

mmol/l

0.45

215

Allergic contact dermatitis

330

0.97

0.03

1.3

1.4

6.43

6.40

mmol/l

0.02

312

Internal derangement of knee

137

1380

0.99

0.02

1.3

6.37

6.34

mmol/l

0.05

125

1268

Mixed hyperlipidaemia

132

1.06

0.02

1.6

1.4

7.97

6.35

mmol/l

1.03

123

Diseases of the ear and mastoid process

504

2540

1.00

0.02

1.3

6.33

6.24

mmol/l

0.28

468

2336

Benign leiomyoma with endometriosis

379

0.98

0.02

1.4

1.3

6.78

6.62

mmol/l

0.13

353

Mixed conductive and sensorineural hearing loss

441

1.02

0.02

1.2

1.4

6.51

6.35

mmol/l

0.19

409

Pollen allergy

279

1.03

0.02

1.3

6.54

6.12

mmol/l

0.33

257

Dislocation, sprain and strain of joint and ligaments of hip

103

1.07

0.02

1.6

1.5

6.42

6.53

mmol/l

0.10

Mood disorders, excluding more controls

370

2260

1.00

0.02

1.3

6.46

6.30

mmol/l

0.48

335

2110

Cervicalgia

672

1.01

0.01

1.3

1.4

6.75

6.34

mmol/l

0.45

628

Speech disturbances, not elsewhere classified

317

0.98

0.01

1.5

1.4

6.17

6.61

mmol/l

0.38

296

Inflammatory diseases of female pelvic organs

150

1137

0.99

0.01

1.3

6.25

6.40

mmol/l

0.28

138

1064

Diseases of appendix

273

2478

1.00

0.01

1.3

6.33

6.24

mmol/l

0.20

248

2283

Malignant neoplasm of prostate

237

1490

1.00

0.01

1.5

1.4

6.07

6.28

mmol/l

0.49

208

1381

Other disorders of conjunctiva

503

1.01

0.01

1.4

6.47

6.42

mmol/l

0.05

465

Other vitreous opacities

116

0.95

0.00

1.3

1.4

5.33

6.65

mmol/l

0.91

108

Simple and mucopurulent chronic bronchitis

154

1.04

0.00

1.5

1.4

5.23

6.75

mmol/l

1.63

146

Other and/or unspecified nontoxic goitre

226

0.97

0.00

1.5

1.4

6.52

6.59

mmol/l

0.04

215

Other extrapyramidal and movement disorders in other diseases

784

1.01

0.00

1.3

1.4

5.83

6.41

mmol/l

1.07

723

Disorders of conjunctiva

280

2343

1.00

0.00

1.3

6.13

6.32

mmol/l

0.60

257

2165

TMD related operations

376

1.01

0.00

1.3

1.4

6.13

6.18

mmol/l

0.05

345

Other specific joint derangements/joint disorders

263

1764

1.00

0.00

1.4

1.3

6.29

6.31

mmol/l

0.04

243

1625

Postprocedural disorders of nervous system

125

0.96

0.00

1.2

1.3

5.92

6.39

mmol/l

0.28

113

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

135

1.04

0.00

1.5

1.3

5.78

6.48

mmol/l

0.85

128

Endovascular or surgical operations to intracerebral aneurysms

179

1.01

0.00

1.4

5.53

6.59

mmol/l

1.62

164

Noninflammatory disorders of female genital tract

116

586

1.00

0.00

1.3

6.29

6.40

mmol/l

0.18

108

554

Examination and encounter for administrative purposes

146

1.03

0.00

1.7

1.3

6.68

6.00

mmol/l

0.58

137

Oxicams

124

703

1.00

0.00

1.3

1.4

5.84

6.48

mmol/l

1.86

113

659

Glaucoma-related operations

206

1.02

0.00

1.3

1.4

6.24

6.62

mmol/l

0.23

197

Glaucoma, exfoliation

447

1.01

0.00

1.4

5.83

6.58

mmol/l

1.15

412

Other degenerative diseases of the nervous system

115

872

1.00

0.00

1.2

1.4

6.13

6.12

mmol/l

0.02

103

802

Other/unspecified disorders of vestibular function

122

0.98

0.00

1.7

1.4

7.72

6.84

mmol/l

0.51

112

Premature rupture of membranes

200

0.99

0.00

1.1

1.3

5.79

6.11

mmol/l

0.35

178

Endometriosis ASRM stages 1,2

298

1.01

0.00

1.1

1.3

5.91

6.29

mmol/l

0.38

278

Other congenital malformations

154

0.97

0.00

1.5

1.3

6.77

6.37

mmol/l

0.15

140

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

143

0.98

0.00

1.5

1.4

6.57

6.92

mmol/l

0.20

131

Discharge of firework

0.00

0.0

1.2

—

6.86

—

Use of peginterferon beta-1a

0.00

0.0

1.0

—

6.00

—

Social disorders starting during childhood or adolecense, excluding more controls

0.00

0.0

1.2

—

7.70

—

Porphyria cutanea tarda

0.00

0.0

1.6

—

6.82

—

Pedestrian injured in collision with railway train or railway vehicle

0.00

0.0

1.3

—

6.28

—

Other porphyria

0.00

0.0

1.3

—

6.62

—

Precocious central puberty

0.00

0.0

1.3

—

5.70

—

Eccrine sweat disorders

0.00

0.0

1.1

—

6.16

—

Relapsing fevers

0.00

0.0

1.1

—

7.16

—

Flexion deformity

0.00

0.0

1.0

—

6.90

—

Other chromosome abnormalities, not elsewhere classified

0.00

0.0

1.0

—

7.66

—

Drug-induced aplastic anaemia

0.00

0.0

1.0

—

7.63

—

Maxillary prognathism

0.00

0.0

1.1

—

6.19

—

Hypertrophy of bone

0.00

0.0

1.0

—

6.84

—

Other facial nerve disorders

1.00

0.00

1.0

1.2

6.40

6.89

mmol/l

—

Onychogryphosis

0.00

0.0

1.0

—

6.70

—

Other hypertrichosis

0.00

0.0

1.0

—

6.30

—

Hypospadias

0.00

0.0

1.2

—

7.04

—

Toxic encephalopathy

0.00

0.0

1.0

—

6.83

—

Hirsutism, drug-induced

0.00

0.0

1.0

—

7.33

—

Intentional self-harm by drowning and submersion

0.00

0.0

1.2

—

6.62

—

Benign neoplasm: Respiratory system, unspecified

0.00

0.0

1.7

—

6.33

—

Exposure to smoke, fire and flames

0.95

0.00

1.2

1.3

5.45

6.36

mmol/l

—

Benign neoplasm: Pancreas

0.90

0.00

1.5

1.4

5.97

6.65

mmol/l

—

Benign neoplasm: Female genital organ, unspecified

0.00

0.0

1.2

—

7.34

—

Hypotony of eye

0.00

0.0

1.2

—

6.30

—

Contact with hypodermic needle

0.00

0.0

1.1

—

5.34

—

Actinic reticuloid

0.00

0.0

1.2

—

6.76

—

0.00

0.0

1.2

—

6.68

—

Poikiloderma of Civatte

0.00

0.0

1.2

—

7.68

—

Severe bullous disorders, KELA reimbursement

0.00

0.0

1.2

—

6.20

—

Acanthosis nigricans

0.00

0.0

1.3

—

6.13

—

Changes in corneal membranes

0.00

0.0

1.2

—

6.45

—

Traumatic subcutaneous emphysema

0.00

0.0

1.4

—

5.84

—

Mechanical strabismus

0.00

0.0

1.0

—

6.50

—

Hyperkinetic disorders

0.94

0.00

1.0

1.2

5.66

5.96

mmol/l

—

Polyp of middle ear

0.00

0.0

1.2

—

6.56

—

Female pelvic inflammatory disorders in diseases classified elsewhere

0.00

0.0

1.0

—

6.20

—

Discharge from other and unspecified firearms

0.00

0.0

1.2

—

6.28

—

Muscle strain

0.99

0.00

1.9

1.3

6.24

6.50

mmol/l

—

Palatinal maxillary canine

0.00

0.0

1.0

—

6.40

—

Spina bifida

0.00

0.0

1.0

—

7.28

—

Lichen planopilaris

0.00

0.0

1.3

—

6.13

—

Neurofibromatosis, type 2

0.00

0.0

1.2

—

6.03

—

Fatigue fracture of vertebra

0.00

0.0

1.3

—

6.23

—

Sleepwalking [somnambulism]

0.00

0.0

1.0

—

7.78

—

Reduction defects of lower limb

0.00

0.0

1.0

—

7.40

—

Calcium deposit in bursa

0.00

0.0

1.3

—

5.68

—

Other sudden death, cause unknown

0.00

0.0

1.6

—

5.94

—

Other and unspecified cicatricial alopecia

0.00

0.0

1.0

—

6.78

—

Enterobiasis

0.00

0.0

1.2

—

7.10

—

Degenerative and vascular disorders of ear

0.00

0.0

1.2

—

6.22

—

Drug-induced cataract

0.88

0.00

1.2

8.68

6.29

mmol/l

—

Postpolio syndrome

0.00

0.0

1.2

—

6.93

—

Down's syndrome

0.00

0.0

1.0

—

7.36

—

Complications of the puerperium, not elsewhere classified

0.94

0.00

1.4

1.3

5.56

6.44

mmol/l

—

Post-traumatic wound infection, not elsewhere classified

0.96

0.00

1.4

1.3

5.64

6.51

mmol/l

—

Chloasma

0.00

0.0

1.0

—

6.54

—

Use of bromocriptine

0.00

0.0

1.2

—

6.67

—

Other and unspecified disorders of refraction

0.00

0.0

1.2

—

6.12

—

Phantom limb syndrome with pain

0.00

0.0

1.4

—

7.24

—

Epiphora

0.91

0.00

1.0

1.3

5.27

6.80

mmol/l

—

Injury of nerves and spinal cord at neck level

0.88

0.00

1.2

1.3

7.43

6.51

mmol/l

—

Trigger finger

410

1.00

0.00

1.6

1.3

7.11

6.31

mmol/l

1.00

382

Fractures involving multiple body regions

0.00

0.0

1.5

—

6.60

—

Testicular hypofunction

0.99

0.00

1.3

1.4

8.23

6.25

mmol/l

—

Disorders of puberty, other/unspecified

0.00

0.0

1.2

—

7.12

—

Lipodystrophy, not elsewhere classified

0.00

0.0

1.5

—

6.47

—

Disorders of other digestive organs in diseases classified elsewhere

0.00

0.0

1.4

—

6.16

—

Knuckle pads

0.00

0.0

1.4

—

6.80

—

Disorders of muscle in diseases classified elsewhere

0.00

0.0

1.6

—

6.12

—

Injury of muscle and tendon at neck level

0.00

0.0

1.2

—

6.74

—

Disorders of phosphorus metabolism and phosphatases

0.00

0.0

1.7

—

6.07

—

Pervasive developmental disorders excl. Autism + Asperger

0.00

0.0

1.2

—

6.13

—

Disturbance of activity and attention

0.90

0.00

1.0

1.2

6.24

5.96

mmol/l

—

Phantom limb syndrome

0.00

0.0

1.6

—

6.80

—

Carcinoma in situ of oral cavity and pharynx

0.00

0.0

1.1

—

6.91

—

Carcinoma in situ of oral cavity

0.00

0.0

1.1

—

6.88

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

0.0

1.0

—

7.44

—

Thyrotoxicosis factitia

0.00

0.0

1.0

—

7.02

—

Palatinal maxillary operation

0.00

0.0

1.0

—

6.40

—

Food allergy

0.00

0.0

1.0

—

7.02

—

Cyst of spleen

0.00

0.0

1.0

—

6.68

—

Carcinoma in situ of oral cavity

0.00

0.0

1.0

—

6.48

—

Other cestode infections

0.00

0.0

1.1

—

6.69

—

Lactose intolerance

0.86

0.00

2.4

1.3

6.30

6.84

mmol/l

—

Congenital malformations of spine and bony thorax

0.00

-0.00

0.0

1.0

—

7.63

—

0.00

-0.00

0.0

1.1

—

7.61

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Glucose [Moles/volume] in Pleural fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS